US20050079229A1 - Methods, compositions and systems for the prevention and treatment of diaper rash - Google Patents
Methods, compositions and systems for the prevention and treatment of diaper rash Download PDFInfo
- Publication number
- US20050079229A1 US20050079229A1 US10/626,069 US62606903A US2005079229A1 US 20050079229 A1 US20050079229 A1 US 20050079229A1 US 62606903 A US62606903 A US 62606903A US 2005079229 A1 US2005079229 A1 US 2005079229A1
- Authority
- US
- United States
- Prior art keywords
- composition
- oil
- percent
- weight
- dispenser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 276
- 238000011282 treatment Methods 0.000 title claims abstract description 89
- 206010012444 Dermatitis diaper Diseases 0.000 title claims abstract description 75
- 208000003105 Diaper Rash Diseases 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims description 61
- 230000002265 prevention Effects 0.000 title description 2
- 239000007921 spray Substances 0.000 claims abstract description 70
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 103
- 239000012530 fluid Substances 0.000 claims description 67
- 239000000463 material Substances 0.000 claims description 63
- 235000014692 zinc oxide Nutrition 0.000 claims description 60
- 239000011787 zinc oxide Substances 0.000 claims description 58
- 239000004166 Lanolin Substances 0.000 claims description 41
- 235000019388 lanolin Nutrition 0.000 claims description 41
- 229940039717 lanolin Drugs 0.000 claims description 41
- 235000012716 cod liver oil Nutrition 0.000 claims description 39
- 239000003026 cod liver oil Substances 0.000 claims description 39
- 230000007246 mechanism Effects 0.000 claims description 39
- 235000019271 petrolatum Nutrition 0.000 claims description 34
- 239000003921 oil Substances 0.000 claims description 33
- 235000019198 oils Nutrition 0.000 claims description 33
- 206010021639 Incontinence Diseases 0.000 claims description 27
- 239000004264 Petrolatum Substances 0.000 claims description 27
- 229940066842 petrolatum Drugs 0.000 claims description 27
- 201000004624 Dermatitis Diseases 0.000 claims description 22
- 239000002480 mineral oil Substances 0.000 claims description 19
- 229920002545 silicone oil Polymers 0.000 claims description 18
- 235000010446 mineral oil Nutrition 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000013871 bee wax Nutrition 0.000 claims description 13
- 239000012166 beeswax Substances 0.000 claims description 13
- 229940092738 beeswax Drugs 0.000 claims description 13
- 241000196324 Embryophyta Species 0.000 claims description 12
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 12
- 239000004200 microcrystalline wax Substances 0.000 claims description 12
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 11
- 235000003880 Calendula Nutrition 0.000 claims description 11
- 240000001432 Calendula officinalis Species 0.000 claims description 11
- 235000005865 Symphytum officinale Nutrition 0.000 claims description 11
- 240000002299 Symphytum officinale Species 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 11
- 238000000576 coating method Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 10
- 239000000454 talc Substances 0.000 claims description 10
- 235000012222 talc Nutrition 0.000 claims description 10
- 229910052623 talc Inorganic materials 0.000 claims description 10
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 8
- 235000009827 Prunus armeniaca Nutrition 0.000 claims description 8
- 244000018633 Prunus armeniaca Species 0.000 claims description 8
- 229940086555 cyclomethicone Drugs 0.000 claims description 8
- 239000010466 nut oil Substances 0.000 claims description 8
- 239000012188 paraffin wax Substances 0.000 claims description 8
- 239000005995 Aluminium silicate Substances 0.000 claims description 7
- 240000003538 Chamaemelum nobile Species 0.000 claims description 7
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 7
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 7
- 235000012211 aluminium silicate Nutrition 0.000 claims description 7
- 229940105847 calamine Drugs 0.000 claims description 7
- 229910052864 hemimorphite Inorganic materials 0.000 claims description 7
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000011236 particulate material Substances 0.000 claims description 7
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 6
- 239000003974 emollient agent Substances 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 239000003429 antifungal agent Substances 0.000 claims description 5
- 229940121375 antifungal agent Drugs 0.000 claims description 5
- 229940008099 dimethicone Drugs 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 5
- 235000019717 geranium oil Nutrition 0.000 claims description 5
- 239000010648 geranium oil Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 235000019489 Almond oil Nutrition 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 235000019487 Hazelnut oil Nutrition 0.000 claims description 4
- 235000019483 Peanut oil Nutrition 0.000 claims description 4
- 235000003447 Pistacia vera Nutrition 0.000 claims description 4
- 240000006711 Pistacia vera Species 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 4
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 4
- 235000019485 Safflower oil Nutrition 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- 235000019498 Walnut oil Nutrition 0.000 claims description 4
- 239000008168 almond oil Substances 0.000 claims description 4
- 235000021302 avocado oil Nutrition 0.000 claims description 4
- 239000008163 avocado oil Substances 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 4
- 235000019438 castor oil Nutrition 0.000 claims description 4
- 235000019864 coconut oil Nutrition 0.000 claims description 4
- 239000003240 coconut oil Substances 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 4
- 235000005687 corn oil Nutrition 0.000 claims description 4
- 239000002285 corn oil Substances 0.000 claims description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 4
- 239000008169 grapeseed oil Substances 0.000 claims description 4
- 239000010468 hazelnut oil Substances 0.000 claims description 4
- 229940119170 jojoba wax Drugs 0.000 claims description 4
- 239000008633 juniper tar Substances 0.000 claims description 4
- 235000021388 linseed oil Nutrition 0.000 claims description 4
- 239000000944 linseed oil Substances 0.000 claims description 4
- 235000019488 nut oil Nutrition 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 239000000312 peanut oil Substances 0.000 claims description 4
- 239000010665 pine oil Substances 0.000 claims description 4
- 239000010491 poppyseed oil Substances 0.000 claims description 4
- 239000008165 rice bran oil Substances 0.000 claims description 4
- 235000005713 safflower oil Nutrition 0.000 claims description 4
- 239000003813 safflower oil Substances 0.000 claims description 4
- 239000011343 solid material Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008170 walnut oil Substances 0.000 claims description 4
- 239000010497 wheat germ oil Substances 0.000 claims description 4
- 235000019809 paraffin wax Nutrition 0.000 claims 7
- 230000002335 preservative effect Effects 0.000 claims 3
- 244000000231 Sesamum indicum Species 0.000 claims 2
- 229960000829 kaolin Drugs 0.000 claims 2
- 229940114937 microcrystalline wax Drugs 0.000 claims 2
- 229940033134 talc Drugs 0.000 claims 2
- 239000003595 mist Substances 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 54
- 239000004615 ingredient Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 13
- 208000010201 Exanthema Diseases 0.000 description 10
- 201000005884 exanthem Diseases 0.000 description 10
- 239000002674 ointment Substances 0.000 description 10
- 206010037844 rash Diseases 0.000 description 10
- 239000007789 gas Substances 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 7
- 239000002085 irritant Substances 0.000 description 6
- 231100000021 irritant Toxicity 0.000 description 6
- 229940099367 lanolin alcohols Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- -1 baby wipes Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 239000000443 aerosol Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000020221 chamomile extract Nutrition 0.000 description 4
- 229940119217 chamomile extract Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010012434 Dermatitis allergic Diseases 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 244000040738 Sesamum orientale Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004479 aerosol dispenser Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 208000005005 intertrigo Diseases 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- ALEVUYMOJKJJSA-UHFFFAOYSA-N 4-hydroxy-2-propylbenzoic acid Chemical compound CCCC1=CC(O)=CC=C1C(O)=O ALEVUYMOJKJJSA-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000159241 Toxicodendron Species 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 229940048299 acetylated lanolin alcohols Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229940075960 desitin Drugs 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000006223 plastic coating Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Definitions
- the present invention relates to methods, compositions and systems for the prevention and treatment of diaper rash.
- Diaper rash (also referred to as diaper dermatitis or incontinent dermatitis) is a common form of irritation and inflammation affecting both infants and incontinent adults, typically in those areas normally covered by a diaper or in areas immediately adjacent to the diaper area. It is generally accepted that diaper rash is a condition that is, in its most simple stages, a contact irritant dermatitis. The irritation of simple diaper rash results from extended contact of the skin with urine, or feces, or both. Diapers are worn to catch and hold the body waste, but generally hold the waste in direct contact with the skin until changed, sometimes for extended periods of time. The same is true for an incontinence pad, or incontinence brief.
- rash is a wide variety of related conditions including, for example, friction rash, irritant rash, allergic rash, intertrigo, seborrhea rash and psoriasis.
- Friction rash is the most common form of diaper rash, and affects almost all infants at some time. It is most common on areas where friction is most pronounced, such as the inner thighs, or under the elastic of diapers that are too tight. It comes and goes quickly, and responds well to frequent diaper changes, airing out, and protective barriers. Irritant rash is usually most conspicuous on the exposed areas, such as the round part of the buttocks.
- Allergic rash may occur in combination with an irritant rash or by itself. It is also more common on exposed areas, and the rash resembles poison oak. Intertrigo is caused by moist heat, such as that commonly occurs deep in skin folds. The involved skin looks thin, as if it has lost several layers. Seborrhea rash is a salmon-colored, greasy rash with yellowish scales, and is also typically worse in skin folds. Psoriasis is a stubborn rash that does not necessarily look distinctive.
- diaper rash is also intended to refer to skin irritations at other areas of the human body that may be caused by prolonged exposure to, for example, moisture, heat, irritants, enzymes and/or pressure.
- Skin wetness appears to be the common denominator underlying the various causes of diaper rash. Urinary wetness increases skin friction, raises the skin pH, makes the skin less cohesive, and makes it more permeable. These effects combine to intensify the action of stool enzymes or other irritants that then inflame the skin. Even skin lesions of systemic illnesses tend to concentrate in areas where the skin is already damaged. In a typical diaper rash, with the protective layer of the outermost layer of skin (the stratum corneum) damaged, microorganisms such as yeast or bacteria can more readily invade the inflamed skin.
- Such a strategy would include frequent diaper changing, reduced use of plastic pants, triple diapering, careful washing and sterilization of diapers, treatment with an anti-Candidal agent, reduction of inflammation (by topical application of a low potency glucocorticoid steroid), and the possible use of a bacteriostatic agent as a prophylactic measure in the perineal rinse.
- an occlusive, barrier-type topical such as petrolatum or zinc oxide
- ointments creams or lotions known and available in the market for the treatment of diaper rash.
- Most of these products include ingredients that offer some beneficial property to the product, for example, by acting as a water repellant, emollient, neutralizer or antibiotic.
- ingredients that are commonly included in such ointments are mineral oil, silicone fluids (e.g. dimethicone and cyclomethicone), petrolatum, cod liver oil, lanolin, zinc oxide, talc, calamine, kaolin, topical starch and allantoin.
- Desitin® ointment (Pfizer, Inc.) is probably the most common topical used in treating diaper rash. It contains common barrier materials (zinc oxide and petrolatum) and additionally contains two common skin conditioning agents (cod liver oil and lanolin).
- Examples of patents that describe various diaper rash treatment compositions include the following: U.S. Pat. No. 5,110,593 to Benford, U.S. Pat. No. 5,300,286 to Gee, U.S. Pat. No. 5,436,007 to Hartung et al., U.S. Pat. No. 5,744,469 to Tran, U.S. Pat. No. 4,857,321 to Thomas, U.S. Pat. No. 5,229,105 to Wilmsmann, U.S. Pat. No. 5,091,193 to Enjolras et al., U.S. Pat. No. 5,869,071 to Wieselman et al., U.S. Pat. No.
- the present invention provides methods, compositions and systems for administering diaper rash compositions to a selected skin treatment area without the mess, inconvenience and inefficiency experienced in the prior art.
- the present invention addresses a number of problems associated with currently-known diaper rash treatments by providing methods, compositions and systems for diaper rash treatment involving application of a treatment composition as an atomized spray.
- Provided by the invention are systems for applying a variety of diaper rash treatment compositions to a selected treatment area without the need for the person administering the treatment to directly contact the composition or the skin of the patient.
- a method for treating diaper rash comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container, (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises at least about 1 percent solid particulate material by weight and at least about 20 percent by weight of a fluid base material.
- the solid material is preferably particulate zinc oxide.
- a method for treating diaper rash comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container; (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material.
- a method for treating diaper rash comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container; (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey.
- the invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises at least about 1 percent particulate zinc oxide by weight and at least about 20 percent by weight of a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- the invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- the invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey and a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- a method for treating diaper rash comprising (1) selecting a substantially clean skin treatment area afflicted by incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (2) propelling toward the skin treatment area an atomized spray comprising a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise.
- An additional object of the invention is to provide novel methods, compositions and systems for preventing or treating diaper rash whereby a treatment composition may be administered to a skin surface by atomizing the composition and propelling the atomized composition toward the skin surface.
- FIG. 1 is a side elevational view, with a cut-out portion, of an atomizing spray dispenser in accordance with one embodiment of the invention.
- FIG. 2 is a sectional side elevational view of a representative atomizing pump spray dispenser in accordance with another embodiment of the invention.
- FIG. 3 is a sectional side elevational view of a representative piston-style dispenser in accordance with another embodiment of the invention.
- FIG. 4 is a sectional side elevational view of a representative bag-in-can style dispenser in accordance with another embodiment of the invention.
- FIG. 5 is a sectional side elevational view of a representative bag-in-can style dispenser in accordance with another embodiment of the invention.
- FIG. 6 is a sectional side elevational view of a representative aerosol dispenser in accordance with another embodiment of the invention.
- a diaper rash treatment composition 5 is placed into an atomizing spray dispenser 10 .
- the dispenser is preferably a container 20 equipped with a spray delivery mechanism 24 configured to atomize and propel the composition toward a treatment surface.
- Compositions described herein exhibit excellent features for the treatment of diaper rash.
- the composition forms a buttery layer, or coating, over the surface, thereby providing a barrier to moisture, and a soothing function to the skin.
- the composition preferably has a viscosity of from about 1 to about 1000 centipoise. More preferably, the viscosity of the composition is from about 20 to about 650 centipoise, more preferably from about 100 to about 600 centipoise, and most preferably from about 400 to about 500 centipoise.
- the composition may comprise a liquid, a combination of liquids or a combination of one or more liquids and one or more solids that features a suitable viscosity. While a variety of additional ingredients may be included in an inventive composition, as discussed more fully below, an important ingredient in an inventive composition is a fluid base material.
- fluid base material is used herein to refer to a fluid into which additional ingredients may be mixed, dissolved and/or suspended.
- the fluid base material selected is preferably an oil having a viscosity of from about 1 centipoise to about 1000 centipoise.
- Excellent oils that may be used are mineral oils, silicone oils, plant-based oils or mixtures thereof.
- mineral oil is used herein to refer to a liquid petroleum derivative.
- mineral oils examples include Witco Corporation's CARNATION® Mineral Oil (viscosity range of 9-12 centipoise) or Penreco Corporation's DRAKEOL® Mineral Oil (Drakeol 7 having a viscosity of 9-11 centipoise).
- silicone oil is used herein to refer to a liquid silicone composition.
- Excellent silicone oils that may be used are cyclomethicone, dimethicone and derivatives thereof, and commercially available silicone oils include Dow Corning Corporation's 200 polydimethylsiloxane fluids and GE Silicones' SF series of low viscosity Dimethyl fluids.
- Cyclomethicone is a volatile compound, and is advantageously included in certain inventive compositions because it evaporates when applied to the skin's surface, making the coating more dry to the touch.
- Other volatile compounds may also be used in this way, including, for example, an organic solvent such as isododecane.
- Such compounds are particularly useful in embodiments of the invention that utilize an aerosol dispenser as the delivery mechanism, as described in more detail below, because the volatile compounds may be used as liquid solvents in the container that evaporate when dispensed from the container to leave a drier coating on the skin surface.
- plant-based oil is used herein to refer to a non-petroleum biomass derived oil, such as a vegetable or fruit oil, including, for example, almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kemal oil, geranium oil, ricebran oil and mixtures thereof. It is of course not intended that the fluid base material be limited to the above exemplary compositions.
- silicone oil and mineral oil another material that may excellently be used as the fluid base material, or included therein, is cod liver oil.
- the fluid base material may alternatively be water, an oil-in-water emulsion or a water-in-oil emulsion.
- inventive compositions including water or an emulsion as the base material are often considered to be more elegant because such compositions have a less greasy feel. Such compositions are also typically less expensive to make because in most places water is readily available and inexpensive. Additional advantages of having water in an inventive composition are that the water provides a source of moisture for dry skin, and that the presence of water allows the inclusion of additional water-loving ingredients that would not become suitably dissolved or dispersed in an oil-based composition.
- an emulsifying agent will typically be necessary to produce a stable mix of the water and nonaqueous ingredients in the composition.
- suitable emulsifiers include cetyl alcohol, stearyl alcohol, cetearyl alcohol and glycerol monolaurate. It is of course not intended that this list be limiting but simply provide examples of emulsifiers that may be used in accordance of the invention. Additional suitable emulsifiers are set forth on pages 90 to 94 of the C.T.F.A. Cosmetic Ingredient Handbook, First Edition, 1988, which is hereby incorporated by reference. Further guidance to the preparation of stable emulsions generally may be found in U.S. Pat. No. 5,417,961 to Nearn et al., which is hereby incorporated herein by reference in its entirety.
- the composition comprises at least about 1 percent solid particulate material by weight and at least about 20 percent by weight of a fluid base material.
- the solid particulate material is preferably particulate zinc oxide.
- the zinc oxide preferably has an average particle size of from about 0.01 microns to about 100 microns, more preferably from about 0.01 microns to about 10 microns and most preferably from about 0.01 microns to about 1 micron.
- microfine zinc oxide particles of from about 0.01 microns to about 0.1 microns are commonly referred to as microfine zinc oxide particles.
- a feature of microfine zinc oxide that is desirable in some applications is that the microfine zinc oxide is translucent when dispersed in a conventional fluid base material. Inventive formulations including microfine zinc oxide therefore do not have the characteristic opaque white appearance of formulations including zinc oxide having larger particle sizes. It is also believed that microfine zinc oxide provides additional advantages over larger particulates, including a smoother film coating on the skin, lower viscosity at the same overall zinc oxide loading, better penetration of the zinc oxide into the skin's cracks and crevices, more even coverage with the finer particles, and higher surface area providing for more reaction/therapeutic activity.
- zinc oxide encompass coated zinc oxide.
- a typical coating is silicone-based and is used to help disperse the zinc oxide in solution and to lower the viscosity of a zinc oxide mixture. It has been reported that uncoated zinc oxide particles swell in certain solvents, such as, for example, octyl palmitate.
- An advantage of coating in certain embodiments of the invention is that silicone coated zinc oxide particles are hydrophobic, non-reactive and not affected by water. Coated hydrophobized zinc oxides or particles also have a significantly decreased photoreactivity, which makes them more resistant to degradation and more chemically inert than non-coated zinc oxides. Hydrophobized zinc oxide is therefore particularly useful in compositions that are applied to skin that is exposed to sunlight or other ultraviolet radiation
- the ratio of zinc oxide to fluid base material in this composition is preferably selected such that the composition has a suitable viscosity at a given temperature as described above. It is readily understood that the ratio selected is dependent upon the desired viscosity for a given system. For example, different delivery systems may function optimally when used to deliver compositions having different overall viscosities. Further, the preferred ratio also depends upon the viscosity of the fluid base material selected for use and upon the particle size distribution of the zinc oxide. These and other factors may be readily determined and considered by a person of ordinary skill in the art, without undue experimentation, to make an inventive composition having a suitable viscosity.
- composition in this aspect of the invention preferably comprises from about 1 to about 40 percent zinc oxide by weight, more preferably from about 5 to about 25 percent and, most preferably, from about 10 to about 15 percent.
- the composition also preferably comprises from about 20 to about 99 percent fluid base material by weight, more preferably from about 33 to about 80 percent and, most preferably from about 55 to about 75 percent.
- the composition may also optionally include one or more of a wide variety of beneficial additives that may be incorporated to provide additional soothing and/or healing to the skin and/or for other reasons.
- the composition may comprise lanolin to improve the skin conditioning quality of the composition.
- lanolin refers to the various forms of lanolin and its derivatives, including, for example, lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, ethoxylated lanolin, ethoxylated lanolin alcohols, ethoxylated cholesterol, propoxylated lanolin alcohols, acetylated lanolin alcohols, lanolin alcohols linoleate, lanolin alcohols ricinoleate, acetate of lanolin alcohols, ricinoleate, acetate of ethoxylated alcohols-esters, hydrogenolysis of lanolin, ethoxylated hydrogenated
- compositions may also desirably include paraffin, microcrystalline wax and/or petrolatum to provide an excellent moisture barrier material.
- Additional ingredients that may optionally be included in an inventive composition are fragrances, dyes, preservatives, anti-bacterial agents, anti-fungal agents and emollients. It is of course not intended that this list limit the invention, but simply provide examples of ingredients that might be included in inventive compositions.
- the composition may comprise one or more different solids as an alternative to zinc oxide or in addition to zinc oxide, such as, for example, talc, calamine or kaolin.
- the composition may also preferably include from about 0 to about 16 percent lanolin by weight, more preferably from about 5 to about 15 percent and, most preferably from about 5 to about 10 percent; from about 0 to about 25 percent petrolatum by weight, more preferably from about 5 to about 15 percent and, most preferably from about 5 to about 10 percent; and from about 0 to about 12 percent cod liver oil by weight, more preferably from about 5 to about 12 percent and, most preferably from about 5 to about 10 percent.
- An excellent composition in the practice of the invention comprises from about 1 to about 40 percent zinc oxide, from about 20 to about 99 percent fluid base material, from about 0 to about 16 percent lanolin, from about 0 to about 12 percent cod liver oil and from about 0 to about 25 percent petrolatum, all by weight.
- the fluid base material comprises from about 20 to about 100 percent mineral oil and from about 0 to about 20 percent silicone oil by weight.
- the fluid base material may comprise from about 20 to about 100 percent silicone oil and from about 0 to about 20 percent mineral oil by weight.
- Another preferred composition comprises from about 5 to about 25 percent zinc oxide, from about 33 to about 80 percent fluid base material, from about 5 to about 15 percent lanolin, from about 5 to about 12 percent cod liver oil and from about 5 to about 15 percent petrolatum, all by weight.
- An additional preferred composition comprises from about 10 to about 15 percent zinc oxide, from about 55 to about 75 percent fluid base material, from about 5 to about 10 percent lanolin, from about 5 to about 10 percent cod liver oil and from about 5 to about 10 percent petrolatum, all by weight.
- the composition may also advantageously include from about 5 to about 10 percent talc and/or microcrystalline wax to increase the viscosity of the composition.
- a composition that has been found to have particularly excellent features in accordance with the invention comprises about 25 percent zinc oxide, about 5 percent lanolin, about 5 percent petrolatum, about 5 percent microcrystalline wax, about 10 percent cod liver oil, about 40 percent mineral oil and about 10 percent cyclomethicone, all by weight.
- a diaper rash treatment composition that comprises a fluid base material and a source of vitamin A (also referred to as “retinol”) and vitamin D (also referred to as “cholecalciferol”).
- vitamin A also referred to as “retinol”
- vitamin D also referred to as “cholecalciferol”
- An excellent source of vitamins A and D in this aspect of the invention is cod liver oil; however, it is understood that alternate sources may be used as alternatives, or in addition to, cod liver oil.
- the vitamin source may comprise purified vitamin A, purified vitamin D and/or vitamin A palmitate.
- the composition preferably comprises lanolin, petrolatum, cod liver oil and a fluid base material (which may also include cod liver oil).
- An excellent composition for example, comprises from about 1 to about 16 percent lanolin, from about 47 to about 97 percent fluid base material, from about 1 to about 12 percent cod liver oil and from about 1 to about 25 percent petrolatum, all by weight.
- Another preferred composition comprises from about 5 to about 16 percent lanolin, from about 57 to about 85 percent fluid base material, from about 5 to about 12 percent cod liver oil and from about 5 to about 15 percent petrolatum, all by weight.
- An additional preferred composition comprises from about 10 to about 16 percent lanolin, from about 57 to about 70 percent fluid base material, from about 10 to about 12 percent cod liver oil and from about 10 to about 15 percent petrolatum, all by weight. It is understood that, where the fluid base material wholly or partially comprises cod liver oil, the cod liver oil is intended to satisfy the recitation of the cod liver oil and the fluid base material.
- a composition that has been found to have particularly excellent features in accordance with the invention comprises about 10 percent cod liver oil, about 10 percent lanolin, about 10 percent petrolatum, about 8 percent microcrystalline wax, about 47 percent mineral oil, and about 15 percent cyclomethicone, all by weight.
- a diaper rash treatment composition that is made using natural ingredients.
- the composition preferably comprises a fluid base material and a solid particulate material or an herbal extract selected from the group consisting of calendula, chamomile, comfrey and mixtures thereof.
- the fluid base material in this aspect of the invention is preferably a plant-based oil, a silicone oil, water or a mixture thereof.
- plant-based oils that may be advantageously selected include almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kemal oil, geranium oil, ricebran oil and mixtures thereof.
- Beneficial additives that may be included in this aspect of the invention include, for example, lanolin, cod liver oil, microcrystalline wax, bees wax and derivatives thereof.
- Derivatives of bees wax may include, for example, bees wax with ethoxylated sorbitol of varying ethylene oxide content and dimethicone copolyol beeswax.
- An excellent composition for use in accordance with this aspect of the invention comprises from about 1 to about 15 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 50 to about 99 percent fluid base material, from about 0 to about 15 percent lanolin, and from about 0 to about 20 percent bees wax, all by weight.
- the extracts are preferably “(4:1)” extracts, wherein the designation “(4:1)” is used to identify the weight ratio of solvent to herb used to make the extract using extraction methods known in the art. It is of course not intended that the invention be limited by the manner in which such an extract is prepared, it being understood that a wide variety of ratios, and a wide variety of extracts, may be used.
- Another preferred composition comprises from about 1 to about 9 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 67 to about 99 percent fluid base material, from about 0 to about 12 percent lanolin, and from about 0 to about 12 percent bees wax, all by weight.
- An additional preferred composition comprises from about 3 to about 9 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 81 to about 99 percent fluid base material, from about 0 to about 5 percent lanolin, and from about 0 to about 5 percent bees wax, all by weight.
- a composition that has been found to have particularly excellent features in accordance with the invention comprises about 3 percent calendula extract, about 3 percent chamomile extract, about 3 percent comfrey extract, about 5 percent lanolin, about 5 percent beeswax, about 1 percent lavender oil, about 1 percent geranium oil, about 54 percent sunflower seed oil and about 25 percent cyclomethicone, all by weight.
- inventive compositions may be included in inventive compositions, including conventional additives typically employed in skin care compositions.
- fragrance oils may be used to mask the odor of other ingredients and/or for cosmetic appeal.
- Dyes may also be used to color the composition.
- preservatives such as, for example, DMDM Hydantoin, methylparaben or other esters of parahydroxy benzoic acid, and the ester of propylparahydroxy benzoic acid and benzethonium chloride may be used.
- Other emollients such as aloe vera and vitamins A, D and E may also be used.
- Emulsion compositions made in accordance with the invention can also optionally include additional active ingredients such as antimicrobial agents, antibacterial agents and antifungal agents.
- An inventive composition may be made by mixing the ingredients and heating the mixture to an elevated temperature below the decomposition temperature of the ingredients. Heating is preferred to ensure that solid ingredients are melted, dissolved and/or dispersed in the composition and to more efficiently and stably achieve an acceptable degree of mixing.
- the mixture is preferably heated to a temperature in a range of from about 40° C. to about 75° C.
- temperature sensitive ingredients such as, for example, herbal ingredients and cod liver oil
- cod liver oil is used as the fluid base material, it is understood that the mixing should be conducted at a temperature below the decomposition temperature of the cod liver oil.
- a high shear mixer such as a triple roll mixer or Charles Ross & Son Company's high-speed mixer-emulsifier, may advantageously be used to assist in the development of a uniform, stable composition.
- a composition made or selected in accordance with the invention is preferably applied to a skin treatment surface by atomizing the composition 5 and propelling the atomized composition toward the surface using a suitable atomizing spray dispenser 10 comprising a container 20 and an atomizing spray delivery mechanism 24 .
- the atomizing spray delivery mechanism 24 preferably releases the composition 5 from the container 20 through an outlet port 28 when a valve is mechanically actuated.
- the mechanism 24 preferably features a reciprocating actuator 26 .
- an excellent atomizing spray delivery mechanism that may be used in accordance with the invention is an atomizing pump spray dispenser 40 , a representative example of which is depicted in FIG. 2 .
- the term “atomizing pump spray dispenser” is intended to refer to a device that, upon activation of a mechanical pump, such as gear pump 43 of FIG. 2 , draws a composition 5 from a container 20 , atomizes the composition, and propels the atomized composition substantially in a predetermined direction. It is understood that the composition 5 drawn from container 20 preferably enters a conduit in fluid communication with the pump and having an inlet port 42 positioned near the bottom of container 20 . “Atomizing” a composition refers to the separation of the composition into relatively small unitary masses (i.e., typically on the order of about 1 to about 100 microns).
- pump dispenser has been used in the prior art to refer to devices for drawing a cream, lotion or ointment from a container and propelling a stream of the cream, lotion or ointment, such as, into the palm of ones hand.
- This type of dispenser is distinguished from an “atomizing pump spray dispenser” as described herein, because a pump dispenser for propelling a stream of a cream, lotion or ointment is incapable of atomizing the cream, lotion or ointment into an atomized mist or spray.
- the unitary masses when propelled from an atomizing pump spray dispenser, form a mist or a spray. When the atomized composition is directed toward a given surface at a suitable velocity, the unitary masses adhere to the surface to provide a thin, often buttery, coating of the composition on the surface.
- atomizing pump spray dispensers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition. While it is not intended that the invention be limited by the design of the atomizing pump spray dispensers, representative examples are set forth in U.S. Pat. No. 5,639,025 to Bush, U.S. Pat. No. 5,881,925 to Ando and U.S. Pat. No. 5,249,747 to Hanson et al.
- pressure release device is intended to refer to a device that contains a composition under pressure, and, when actuated, opens a valve to release the composition from the pressurized compartment, atomizes the composition, and propels the atomized composition substantially in a predetermined direction by using energy provided by the force of the pressure.
- the composition may advantageously be maintained under pressure by placing the composition in a pressurized compartment of the container.
- the composition is releasably contained in the pressurized compartment and when a manually actuating valve is opened, the composition is released from the compartment, atomized, and released from the device as an atomized spray.
- the pressure release device is a piston-style dispenser 60 , and pressure is maintained on the composition 5 by pressure of a piston 62 .
- the pressure of the piston 62 may be provided by placement of a pressurized gas 64 beneath the piston 62 , which placement may be advantageously achieved by introducing gas 64 through a gas charging port 66 .
- pressure on the piston may be achieved by a spring loaded mechanism beneath the piston.
- piston-style dispensers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition contained therein. While it is not intended that the invention be limited by the design of the piston-style can, representative examples are set forth in U.S. Pat. No. 4,134,523 to Hansen.
- the pressure release device comprises a bag-in-can-style dispenser 70 .
- the pressurized compartment of such a container is a polymeric bag 72 received inside a rigid can 73 . Pressure is maintained on the composition 5 inside the bag 72 .
- the pressure is maintained upon the composition by a pressurizing gas 74 received in the can 73 and externally to the bag 72 .
- the pressurizing gas 74 may be advantageously placed in the can 73 by introducing gas 74 through a gas charging port 76 .
- the bag 72 is an elastic shape-memory bag, and pressure is maintained upon the composition 5 by maintaining the bag in an expanded state. This type of container is commonly referred to as a bladder pack container.
- bag-in-can-style containers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition contained therein. While it is not intended that the invention be limited by the design of the bag-in-can-style container, representative examples are set forth in U.S. Pat. No. 3,788,521 to Laauwe, U.S. Pat. No. 4,510,734 to Banks et al., and U.S. Pat. No. 5,249,747 to Hanson et al.
- an aerosol device 80 is intended to refer to a device that delivers the diaper rash spray treatment composition by entraining the same in a carrier stream comprising an inert pressurized propellant gas 82 .
- the composition is released from the container, entrained in a gaseous stream, atomized, and propelled substantially in a predetermined direction by using energy provided by the pressurized gas.
- composition and carrier gas may alternately be contained in the container in a pre-mixed form, whereby actuation of the device results in a substantially constant release of the mixture.
- aerosol containers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the compositions contained therein. While it is not intended that the invention be limited by the design of the aerosol container, representative examples are set forth in U.S. Pat. No. 4,001,391 to Feinstone et al., U.S. Pat. No. 4,187,985 to Goth, U.S. Pat. No. 4,239,407 to Knight, U.S. Pat. No. 4,495,168 to Schmolka, U.S. Pat. No. 5,788,389 to de Laforcade, and U.S. Pat. No. RE030,093 to Burger.
- FIG. 1 an excellent system that may be used to achieve efficient treatment of diaper rash is depicted in FIG. 1 and includes a diaper rash treatment composition as described herein and an atomizing spray dispenser 10 for atomizing the composition and delivering the atomized composition to a skin treatment area.
- the dispenser 10 preferably comprises a container 20 , an atomizing spray delivery mechanism 24 affixed to the container 20 , and the composition 5 positioned in the container 20 .
- the mechanism preferably comprises an inlet port in fluid communication with the interior of the container for receiving the composition, a device for atomizing the composition, and an outlet port for propelling the atomized composition substantially in a predetermined direction. It is readily understood that, in use, the inlet port must be in contact with the composition.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Provided by the invention are systems for applying diaper rash treatment compositions to a selected skin treatment area without the need for the person administering the treatment to directly contact the composition or the skin of the patient. Application of the diaper rash treatment composition is accomplished by forming the composition into a mist or spray using an atomizing spray dispenser.
Description
- 1. Field of the Invention
- The present invention relates to methods, compositions and systems for the prevention and treatment of diaper rash.
- 2. Discussion of Related Art
- Diaper rash (also referred to as diaper dermatitis or incontinent dermatitis) is a common form of irritation and inflammation affecting both infants and incontinent adults, typically in those areas normally covered by a diaper or in areas immediately adjacent to the diaper area. It is generally accepted that diaper rash is a condition that is, in its most simple stages, a contact irritant dermatitis. The irritation of simple diaper rash results from extended contact of the skin with urine, or feces, or both. Diapers are worn to catch and hold the body waste, but generally hold the waste in direct contact with the skin until changed, sometimes for extended periods of time. The same is true for an incontinence pad, or incontinence brief.
- While it is known that body waste causes diaper rash, identification of the precise component or components of the urine and/or feces which are responsible for the resulting irritation of the skin remains the subject of much controversy. The most commonly accepted list of factors linked to diaper rash includes ammonia, bacteria, the products of bacteria action, urine pH, Candida albicans, and moisture.
- Encompassed by the term “diaper rash” are a wide variety of related conditions including, for example, friction rash, irritant rash, allergic rash, intertrigo, seborrhea rash and psoriasis. Friction rash is the most common form of diaper rash, and affects almost all infants at some time. It is most common on areas where friction is most pronounced, such as the inner thighs, or under the elastic of diapers that are too tight. It comes and goes quickly, and responds well to frequent diaper changes, airing out, and protective barriers. Irritant rash is usually most conspicuous on the exposed areas, such as the round part of the buttocks. It tends to spare skin folds and creases, and is generally the result of contact with stool enzymes or irritants such as harsh soaps, baby wipes, detergents or topical medicines. Allergic rash may occur in combination with an irritant rash or by itself. It is also more common on exposed areas, and the rash resembles poison oak. Intertrigo is caused by moist heat, such as that commonly occurs deep in skin folds. The involved skin looks thin, as if it has lost several layers. Seborrhea rash is a salmon-colored, greasy rash with yellowish scales, and is also typically worse in skin folds. Psoriasis is a stubborn rash that does not necessarily look distinctive. Other signs of psoriasis usually accompany the diaper rash, though, such as pitting of the nails or dark red areas with sharp borders and fine silvery scales on the trunk, face, or scalp. In addition to its common appearance in the diaper area, the term diaper rash is also intended to refer to skin irritations at other areas of the human body that may be caused by prolonged exposure to, for example, moisture, heat, irritants, enzymes and/or pressure.
- Skin wetness appears to be the common denominator underlying the various causes of diaper rash. Urinary wetness increases skin friction, raises the skin pH, makes the skin less cohesive, and makes it more permeable. These effects combine to intensify the action of stool enzymes or other irritants that then inflame the skin. Even skin lesions of systemic illnesses tend to concentrate in areas where the skin is already damaged. In a typical diaper rash, with the protective layer of the outermost layer of skin (the stratum corneum) damaged, microorganisms such as yeast or bacteria can more readily invade the inflamed skin.
- Because the suspected agents of diaper rash, discussed above, all possess diverse properties and require varied therapies, conventional methods of treatment for diaper dermatitis have been directed toward a straightforward attempt to minimize the contact of the skin with the feces or urine present in a soiled diaper. An artificial barrier is usually provided between the skin and the body waste to accomplish this. There have also been attempts directed toward counteracting other suspected causes of diaper rash by promoting dryness in the diapered area, and preventing microbial growth and inflammation with conventional agents. Such a strategy would include frequent diaper changing, reduced use of plastic pants, triple diapering, careful washing and sterilization of diapers, treatment with an anti-Candidal agent, reduction of inflammation (by topical application of a low potency glucocorticoid steroid), and the possible use of a bacteriostatic agent as a prophylactic measure in the perineal rinse. However, because the exact components of urine or feces which act as factors or cofactors contributing to diaper dermatitis have never been precisely identified, the most effective method of treating diaper rash to date has been the artificial barrier. This has led to the frequent use of an occlusive, barrier-type topical, such as petrolatum or zinc oxide, to provide protection, preventing the unknown offending component from coming in contact with the skin.
- Presently, there are a wide variety of ointments, creams or lotions known and available in the market for the treatment of diaper rash. Most of these products include ingredients that offer some beneficial property to the product, for example, by acting as a water repellant, emollient, neutralizer or antibiotic. Examples of ingredients that are commonly included in such ointments are mineral oil, silicone fluids (e.g. dimethicone and cyclomethicone), petrolatum, cod liver oil, lanolin, zinc oxide, talc, calamine, kaolin, topical starch and allantoin. For example, Desitin® ointment (Pfizer, Inc.) is probably the most common topical used in treating diaper rash. It contains common barrier materials (zinc oxide and petrolatum) and additionally contains two common skin conditioning agents (cod liver oil and lanolin).
- Examples of patents that describe various diaper rash treatment compositions include the following: U.S. Pat. No. 5,110,593 to Benford, U.S. Pat. No. 5,300,286 to Gee, U.S. Pat. No. 5,436,007 to Hartung et al., U.S. Pat. No. 5,744,469 to Tran, U.S. Pat. No. 4,857,321 to Thomas, U.S. Pat. No. 5,229,105 to Wilmsmann, U.S. Pat. No. 5,091,193 to Enjolras et al., U.S. Pat. No. 5,869,071 to Wieselman et al., U.S. Pat. No. 5,194,261 to Pichierri, U.S. Pat. No. 5,362,488 to Sibley et al. and U.S. Pat. No. 5,762,945 to Ashley et al. These, and all other references cited herein are hereby incorporated by reference herein in their entireties.
- Many recent developments in the field of diaper rash treatment have focused on new ingredients that offer either antibiotic performance or act as a superior moisture barrier. For example, there are a number of pharmaceutical actives that can be used, but these are not available in over-the-counter products. Additionally, there have been proposed lotions having reactive polymeric components that form a plastic coating on the surface of the skin. Examples of such developments include U.S. Pat. No. 5,879,688 to Coury et al., U.S. Pat. No. 5,874,479 to Martin, U.S. Pat. No. 5,762,945 to Ashley, U.S. Pat. No. 5,728,391 to Ikeya et al., U.S. Pat. No. 5,721,306 to Tsipursky et al., U.S. Pat. No. 5,674,912 to Martin, U.S. Pat. No. 5,658,956 to Martin et al., and U.S. Pat. No. 5,618,529 to Pichierri.
- A major drawback of most products currently available for the treatment of diaper rash, however, is that they are very viscous and messy to administer to the skin. Such products require that the person applying the product spread the product by rubbing the same into or over the skin. While this requirement is typically acceptable in the case of a parent applying the product to the skin of an infant child, it is a drawback where a caregiver is in charge of providing such a treatment to multiple persons, especially multiple incontinent adults. The application of the product is messy and awkward because the product is difficult to wash off of ones hand due to its oily, hydrophobic nature. Additionally, the caregiver must first use one set of gloves to clean the patient, and then use another set of gloves to apply the ointment or lotion. This results in wasted time and resources.
- Other new products address the difficulty and mess associated with applying viscous ointments and lotions by providing systems that have pads or other applicators that can be used to smear the ointment onto the skin. A representative example of such a system is set forth in U.S. Pat. No. 4,893,956 to Wojcik et al. A disadvantage of such applicators, however, is that they may become contaminated upon use and should therefore be discarded after a single use.
- The above shortcomings of the prior art are addressed by the present invention, which provides methods, compositions and systems for administering diaper rash compositions to a selected skin treatment area without the mess, inconvenience and inefficiency experienced in the prior art.
- The present invention addresses a number of problems associated with currently-known diaper rash treatments by providing methods, compositions and systems for diaper rash treatment involving application of a treatment composition as an atomized spray. Provided by the invention are systems for applying a variety of diaper rash treatment compositions to a selected treatment area without the need for the person administering the treatment to directly contact the composition or the skin of the patient.
- In one aspect of the invention, there is provided a method for treating diaper rash, the method comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container, (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises at least about 1 percent solid particulate material by weight and at least about 20 percent by weight of a fluid base material. The solid material is preferably particulate zinc oxide.
- In another aspect of the invention, there is provided a method for treating diaper rash, the method comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container; (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material.
- In another aspect of the invention, there is provided a method for treating diaper rash, the method comprising (1) providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container; (2) selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (3) passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey.
- The invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises at least about 1 percent particulate zinc oxide by weight and at least about 20 percent by weight of a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- The invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- The invention provides in another aspect a system for treating diaper rash, the system comprising (1) a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey and a fluid base material; and (2) an atomizing spray dispenser for delivering the composition to a skin treatment area; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container.
- In another aspect of the invention, there is provided a method for treating diaper rash, comprising (1) selecting a substantially clean skin treatment area afflicted by incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and (2) propelling toward the skin treatment area an atomized spray comprising a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise.
- It is an object of the invention to provide novel methods, compositions and systems for preventing or treating diaper rash.
- It is another object of the invention to provide novel methods, compositions and systems for preventing or treating diaper rash whereby a treatment composition may be administered to a skin surface without the need for the person administering the composition to come into contact with the composition or the skin of the patient.
- An additional object of the invention is to provide novel methods, compositions and systems for preventing or treating diaper rash whereby a treatment composition may be administered to a skin surface by atomizing the composition and propelling the atomized composition toward the skin surface.
- Further objects, advantages and features of the present invention will be apparent from the detailed description herein.
- Although the characteristic features of this invention will be particularly pointed out in the claims, the invention itself, and the manner in which it may be made and used, may be better understood by referring to the following description taken in connection with the accompanying figures forming a part hereof.
-
FIG. 1 is a side elevational view, with a cut-out portion, of an atomizing spray dispenser in accordance with one embodiment of the invention. -
FIG. 2 is a sectional side elevational view of a representative atomizing pump spray dispenser in accordance with another embodiment of the invention. -
FIG. 3 is a sectional side elevational view of a representative piston-style dispenser in accordance with another embodiment of the invention. -
FIG. 4 is a sectional side elevational view of a representative bag-in-can style dispenser in accordance with another embodiment of the invention. -
FIG. 5 is a sectional side elevational view of a representative bag-in-can style dispenser in accordance with another embodiment of the invention. -
FIG. 6 is a sectional side elevational view of a representative aerosol dispenser in accordance with another embodiment of the invention. - For purposes of promoting an understanding of the principles of the invention, reference will now be made to particular embodiments of the invention and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the invention, and such further applications of the principles of the invention as described herein being contemplated as would normally occur to one skilled in the art to which the invention pertains.
- Referring to
FIG. 1 , to practice the invention, a diaperrash treatment composition 5 is placed into anatomizing spray dispenser 10. The dispenser is preferably acontainer 20 equipped with aspray delivery mechanism 24 configured to atomize and propel the composition toward a treatment surface. Compositions described herein exhibit excellent features for the treatment of diaper rash. When a proper amount of the composition is atomized and propelled by a suitable atomizing spray delivery mechanism, the composition forms a buttery layer, or coating, over the surface, thereby providing a barrier to moisture, and a soothing function to the skin. - It is preferred that the composition have a suitably low viscosity that it may be readily converted to an atomized spray, but that the viscosity not be too low because a viscosity that is too low may result in the composition running off of the treatment surface. In this regard, the composition preferably has a viscosity of from about 1 to about 1000 centipoise. More preferably, the viscosity of the composition is from about 20 to about 650 centipoise, more preferably from about 100 to about 600 centipoise, and most preferably from about 400 to about 500 centipoise. The composition may comprise a liquid, a combination of liquids or a combination of one or more liquids and one or more solids that features a suitable viscosity. While a variety of additional ingredients may be included in an inventive composition, as discussed more fully below, an important ingredient in an inventive composition is a fluid base material.
- The term “fluid base material” is used herein to refer to a fluid into which additional ingredients may be mixed, dissolved and/or suspended. The fluid base material selected is preferably an oil having a viscosity of from about 1 centipoise to about 1000 centipoise. Excellent oils that may be used are mineral oils, silicone oils, plant-based oils or mixtures thereof. The term “mineral oil” is used herein to refer to a liquid petroleum derivative. Examples of excellent, commercially available mineral oils that may be used in accordance with the invention include Witco Corporation's CARNATION® Mineral Oil (viscosity range of 9-12 centipoise) or Penreco Corporation's DRAKEOL® Mineral Oil (Drakeol 7 having a viscosity of 9-11 centipoise).
- The term “silicone oil” is used herein to refer to a liquid silicone composition. Excellent silicone oils that may be used, for example, are cyclomethicone, dimethicone and derivatives thereof, and commercially available silicone oils include Dow Corning Corporation's 200 polydimethylsiloxane fluids and GE Silicones' SF series of low viscosity Dimethyl fluids. Cyclomethicone is a volatile compound, and is advantageously included in certain inventive compositions because it evaporates when applied to the skin's surface, making the coating more dry to the touch. Other volatile compounds may also be used in this way, including, for example, an organic solvent such as isododecane. Such compounds are particularly useful in embodiments of the invention that utilize an aerosol dispenser as the delivery mechanism, as described in more detail below, because the volatile compounds may be used as liquid solvents in the container that evaporate when dispensed from the container to leave a drier coating on the skin surface.
- The term “plant-based oil” is used herein to refer to a non-petroleum biomass derived oil, such as a vegetable or fruit oil, including, for example, almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kemal oil, geranium oil, ricebran oil and mixtures thereof. It is of course not intended that the fluid base material be limited to the above exemplary compositions. As an alternative to plant-based oil, silicone oil and mineral oil, another material that may excellently be used as the fluid base material, or included therein, is cod liver oil.
- The fluid base material may alternatively be water, an oil-in-water emulsion or a water-in-oil emulsion. Inventive compositions including water or an emulsion as the base material are often considered to be more elegant because such compositions have a less greasy feel. Such compositions are also typically less expensive to make because in most places water is readily available and inexpensive. Additional advantages of having water in an inventive composition are that the water provides a source of moisture for dry skin, and that the presence of water allows the inclusion of additional water-loving ingredients that would not become suitably dissolved or dispersed in an oil-based composition. When water is included in an inventive composition that also comprises one or more oils, it is readily understood that an emulsifying agent will typically be necessary to produce a stable mix of the water and nonaqueous ingredients in the composition. Examples of suitable emulsifiers that may be used include cetyl alcohol, stearyl alcohol, cetearyl alcohol and glycerol monolaurate. It is of course not intended that this list be limiting but simply provide examples of emulsifiers that may be used in accordance of the invention. Additional suitable emulsifiers are set forth on pages 90 to 94 of the C.T.F.A. Cosmetic Ingredient Handbook, First Edition, 1988, which is hereby incorporated by reference. Further guidance to the preparation of stable emulsions generally may be found in U.S. Pat. No. 5,417,961 to Nearn et al., which is hereby incorporated herein by reference in its entirety.
- In one excellent aspect of the invention, the composition comprises at least about 1 percent solid particulate material by weight and at least about 20 percent by weight of a fluid base material. In this aspect of the invention, the solid particulate material is preferably particulate zinc oxide. The zinc oxide preferably has an average particle size of from about 0.01 microns to about 100 microns, more preferably from about 0.01 microns to about 10 microns and most preferably from about 0.01 microns to about 1 micron.
- Zinc oxide particles of from about 0.01 microns to about 0.1 microns are commonly referred to as microfine zinc oxide particles. A feature of microfine zinc oxide that is desirable in some applications is that the microfine zinc oxide is translucent when dispersed in a conventional fluid base material. Inventive formulations including microfine zinc oxide therefore do not have the characteristic opaque white appearance of formulations including zinc oxide having larger particle sizes. It is also believed that microfine zinc oxide provides additional advantages over larger particulates, including a smoother film coating on the skin, lower viscosity at the same overall zinc oxide loading, better penetration of the zinc oxide into the skin's cracks and crevices, more even coverage with the finer particles, and higher surface area providing for more reaction/therapeutic activity.
- It is also intended that the term “zinc oxide” encompass coated zinc oxide. A typical coating is silicone-based and is used to help disperse the zinc oxide in solution and to lower the viscosity of a zinc oxide mixture. It has been reported that uncoated zinc oxide particles swell in certain solvents, such as, for example, octyl palmitate. An advantage of coating in certain embodiments of the invention is that silicone coated zinc oxide particles are hydrophobic, non-reactive and not affected by water. Coated hydrophobized zinc oxides or particles also have a significantly decreased photoreactivity, which makes them more resistant to degradation and more chemically inert than non-coated zinc oxides. Hydrophobized zinc oxide is therefore particularly useful in compositions that are applied to skin that is exposed to sunlight or other ultraviolet radiation
- The ratio of zinc oxide to fluid base material in this composition is preferably selected such that the composition has a suitable viscosity at a given temperature as described above. It is readily understood that the ratio selected is dependent upon the desired viscosity for a given system. For example, different delivery systems may function optimally when used to deliver compositions having different overall viscosities. Further, the preferred ratio also depends upon the viscosity of the fluid base material selected for use and upon the particle size distribution of the zinc oxide. These and other factors may be readily determined and considered by a person of ordinary skill in the art, without undue experimentation, to make an inventive composition having a suitable viscosity. The composition in this aspect of the invention preferably comprises from about 1 to about 40 percent zinc oxide by weight, more preferably from about 5 to about 25 percent and, most preferably, from about 10 to about 15 percent. The composition also preferably comprises from about 20 to about 99 percent fluid base material by weight, more preferably from about 33 to about 80 percent and, most preferably from about 55 to about 75 percent.
- The composition may also optionally include one or more of a wide variety of beneficial additives that may be incorporated to provide additional soothing and/or healing to the skin and/or for other reasons. For example, the composition may comprise lanolin to improve the skin conditioning quality of the composition. It is understood that the term “lanolin” refers to the various forms of lanolin and its derivatives, including, for example, lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, ethoxylated lanolin, ethoxylated lanolin alcohols, ethoxylated cholesterol, propoxylated lanolin alcohols, acetylated lanolin alcohols, lanolin alcohols linoleate, lanolin alcohols ricinoleate, acetate of lanolin alcohols, ricinoleate, acetate of ethoxylated alcohols-esters, hydrogenolysis of lanolin, ethoxylated hydrogenated lanolin and ethoxylated sorbitol lanolin. Another excellent skin conditioning composition that may be included, if not already included in the fluid base material, is cod liver oil. The composition may also desirably include paraffin, microcrystalline wax and/or petrolatum to provide an excellent moisture barrier material. Additional ingredients that may optionally be included in an inventive composition are fragrances, dyes, preservatives, anti-bacterial agents, anti-fungal agents and emollients. It is of course not intended that this list limit the invention, but simply provide examples of ingredients that might be included in inventive compositions. In addition, the composition may comprise one or more different solids as an alternative to zinc oxide or in addition to zinc oxide, such as, for example, talc, calamine or kaolin.
- When including one or more beneficial additives, it is important to consider the effect that the one or more additives have on the overall viscosity of the composition. Thus, adjustments of the zinc oxide to fluid base material ratio may be necessary to achieve a desired viscosity when including one or more beneficial additives to achieve a desired combination of additional features.
- In this aspect of the invention, the composition may also preferably include from about 0 to about 16 percent lanolin by weight, more preferably from about 5 to about 15 percent and, most preferably from about 5 to about 10 percent; from about 0 to about 25 percent petrolatum by weight, more preferably from about 5 to about 15 percent and, most preferably from about 5 to about 10 percent; and from about 0 to about 12 percent cod liver oil by weight, more preferably from about 5 to about 12 percent and, most preferably from about 5 to about 10 percent.
- An excellent composition in the practice of the invention comprises from about 1 to about 40 percent zinc oxide, from about 20 to about 99 percent fluid base material, from about 0 to about 16 percent lanolin, from about 0 to about 12 percent cod liver oil and from about 0 to about 25 percent petrolatum, all by weight. In one preferred embodiment, the fluid base material comprises from about 20 to about 100 percent mineral oil and from about 0 to about 20 percent silicone oil by weight. Alternatively, the fluid base material may comprise from about 20 to about 100 percent silicone oil and from about 0 to about 20 percent mineral oil by weight.
- Another preferred composition comprises from about 5 to about 25 percent zinc oxide, from about 33 to about 80 percent fluid base material, from about 5 to about 15 percent lanolin, from about 5 to about 12 percent cod liver oil and from about 5 to about 15 percent petrolatum, all by weight. An additional preferred composition comprises from about 10 to about 15 percent zinc oxide, from about 55 to about 75 percent fluid base material, from about 5 to about 10 percent lanolin, from about 5 to about 10 percent cod liver oil and from about 5 to about 10 percent petrolatum, all by weight. The composition may also advantageously include from about 5 to about 10 percent talc and/or microcrystalline wax to increase the viscosity of the composition.
- A composition that has been found to have particularly excellent features in accordance with the invention comprises about 25 percent zinc oxide, about 5 percent lanolin, about 5 percent petrolatum, about 5 percent microcrystalline wax, about 10 percent cod liver oil, about 40 percent mineral oil and about 10 percent cyclomethicone, all by weight.
- In an alternate aspect of the invention, there is provided a diaper rash treatment composition that comprises a fluid base material and a source of vitamin A (also referred to as “retinol”) and vitamin D (also referred to as “cholecalciferol”). An excellent source of vitamins A and D in this aspect of the invention is cod liver oil; however, it is understood that alternate sources may be used as alternatives, or in addition to, cod liver oil. For example, the vitamin source may comprise purified vitamin A, purified vitamin D and/or vitamin A palmitate. The composition preferably comprises lanolin, petrolatum, cod liver oil and a fluid base material (which may also include cod liver oil). An excellent composition, for example, comprises from about 1 to about 16 percent lanolin, from about 47 to about 97 percent fluid base material, from about 1 to about 12 percent cod liver oil and from about 1 to about 25 percent petrolatum, all by weight. Another preferred composition comprises from about 5 to about 16 percent lanolin, from about 57 to about 85 percent fluid base material, from about 5 to about 12 percent cod liver oil and from about 5 to about 15 percent petrolatum, all by weight. An additional preferred composition comprises from about 10 to about 16 percent lanolin, from about 57 to about 70 percent fluid base material, from about 10 to about 12 percent cod liver oil and from about 10 to about 15 percent petrolatum, all by weight. It is understood that, where the fluid base material wholly or partially comprises cod liver oil, the cod liver oil is intended to satisfy the recitation of the cod liver oil and the fluid base material.
- A composition that has been found to have particularly excellent features in accordance with the invention comprises about 10 percent cod liver oil, about 10 percent lanolin, about 10 percent petrolatum, about 8 percent microcrystalline wax, about 47 percent mineral oil, and about 15 percent cyclomethicone, all by weight.
- In another excellent aspect of the invention, there is provided a diaper rash treatment composition that is made using natural ingredients. The composition preferably comprises a fluid base material and a solid particulate material or an herbal extract selected from the group consisting of calendula, chamomile, comfrey and mixtures thereof. The fluid base material in this aspect of the invention is preferably a plant-based oil, a silicone oil, water or a mixture thereof. For example, plant-based oils that may be advantageously selected include almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kemal oil, geranium oil, ricebran oil and mixtures thereof. Beneficial additives that may be included in this aspect of the invention include, for example, lanolin, cod liver oil, microcrystalline wax, bees wax and derivatives thereof. Derivatives of bees wax may include, for example, bees wax with ethoxylated sorbitol of varying ethylene oxide content and dimethicone copolyol beeswax.
- An excellent composition for use in accordance with this aspect of the invention comprises from about 1 to about 15 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 50 to about 99 percent fluid base material, from about 0 to about 15 percent lanolin, and from about 0 to about 20 percent bees wax, all by weight. The extracts are preferably “(4:1)” extracts, wherein the designation “(4:1)” is used to identify the weight ratio of solvent to herb used to make the extract using extraction methods known in the art. It is of course not intended that the invention be limited by the manner in which such an extract is prepared, it being understood that a wide variety of ratios, and a wide variety of extracts, may be used.
- Another preferred composition comprises from about 1 to about 9 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 67 to about 99 percent fluid base material, from about 0 to about 12 percent lanolin, and from about 0 to about 12 percent bees wax, all by weight. An additional preferred composition comprises from about 3 to about 9 percent of a member selected from the group consisting of calendula extract, chamomile extract, comfrey extract and mixtures thereof, from about 81 to about 99 percent fluid base material, from about 0 to about 5 percent lanolin, and from about 0 to about 5 percent bees wax, all by weight.
- A composition that has been found to have particularly excellent features in accordance with the invention comprises about 3 percent calendula extract, about 3 percent chamomile extract, about 3 percent comfrey extract, about 5 percent lanolin, about 5 percent beeswax, about 1 percent lavender oil, about 1 percent geranium oil, about 54 percent sunflower seed oil and about 25 percent cyclomethicone, all by weight.
- As mentioned above, other additives may be included in inventive compositions, including conventional additives typically employed in skin care compositions. For example, fragrance oils may be used to mask the odor of other ingredients and/or for cosmetic appeal. Dyes may also be used to color the composition. In addition, preservatives, such as, for example, DMDM Hydantoin, methylparaben or other esters of parahydroxy benzoic acid, and the ester of propylparahydroxy benzoic acid and benzethonium chloride may be used. Other emollients such as aloe vera and vitamins A, D and E may also be used. Emulsion compositions made in accordance with the invention can also optionally include additional active ingredients such as antimicrobial agents, antibacterial agents and antifungal agents.
- An inventive composition may be made by mixing the ingredients and heating the mixture to an elevated temperature below the decomposition temperature of the ingredients. Heating is preferred to ensure that solid ingredients are melted, dissolved and/or dispersed in the composition and to more efficiently and stably achieve an acceptable degree of mixing. The mixture is preferably heated to a temperature in a range of from about 40° C. to about 75° C. When temperature sensitive ingredients, such as, for example, herbal ingredients and cod liver oil, are included in an inventive composition, these ingredients should be added after the mixture's temperature has been lowered to below about 40° C. When cod liver oil is used as the fluid base material, it is understood that the mixing should be conducted at a temperature below the decomposition temperature of the cod liver oil. A high shear mixer, such as a triple roll mixer or Charles Ross & Son Company's high-speed mixer-emulsifier, may advantageously be used to assist in the development of a uniform, stable composition.
- Referring to
FIG. 1 , a composition made or selected in accordance with the invention is preferably applied to a skin treatment surface by atomizing thecomposition 5 and propelling the atomized composition toward the surface using a suitableatomizing spray dispenser 10 comprising acontainer 20 and an atomizingspray delivery mechanism 24. The atomizingspray delivery mechanism 24 preferably releases thecomposition 5 from thecontainer 20 through anoutlet port 28 when a valve is mechanically actuated. Themechanism 24 preferably features areciprocating actuator 26. - An excellent atomizing spray delivery mechanism that may be used in accordance with the invention is an atomizing pump spray dispenser 40, a representative example of which is depicted in
FIG. 2 . As used herein, the term “atomizing pump spray dispenser” is intended to refer to a device that, upon activation of a mechanical pump, such as gear pump 43 ofFIG. 2 , draws acomposition 5 from acontainer 20, atomizes the composition, and propels the atomized composition substantially in a predetermined direction. It is understood that thecomposition 5 drawn fromcontainer 20 preferably enters a conduit in fluid communication with the pump and having aninlet port 42 positioned near the bottom ofcontainer 20. “Atomizing” a composition refers to the separation of the composition into relatively small unitary masses (i.e., typically on the order of about 1 to about 100 microns). - It is important to recognize that the term “pump dispenser” has been used in the prior art to refer to devices for drawing a cream, lotion or ointment from a container and propelling a stream of the cream, lotion or ointment, such as, into the palm of ones hand. This type of dispenser is distinguished from an “atomizing pump spray dispenser” as described herein, because a pump dispenser for propelling a stream of a cream, lotion or ointment is incapable of atomizing the cream, lotion or ointment into an atomized mist or spray. It is understood that the unitary masses, when propelled from an atomizing pump spray dispenser, form a mist or a spray. When the atomized composition is directed toward a given surface at a suitable velocity, the unitary masses adhere to the surface to provide a thin, often buttery, coating of the composition on the surface.
- A wide variety of atomizing pump spray dispensers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition. While it is not intended that the invention be limited by the design of the atomizing pump spray dispensers, representative examples are set forth in U.S. Pat. No. 5,639,025 to Bush, U.S. Pat. No. 5,881,925 to Ando and U.S. Pat. No. 5,249,747 to Hanson et al.
- Another excellent atomizing spray dispenser that may be used in accordance with the invention is a pressure release device. As used herein, the term “pressure release device” is intended to refer to a device that contains a composition under pressure, and, when actuated, opens a valve to release the composition from the pressurized compartment, atomizes the composition, and propels the atomized composition substantially in a predetermined direction by using energy provided by the force of the pressure. The composition may advantageously be maintained under pressure by placing the composition in a pressurized compartment of the container. The composition is releasably contained in the pressurized compartment and when a manually actuating valve is opened, the composition is released from the compartment, atomized, and released from the device as an atomized spray.
- In one excellent embodiment of the invention, a representative example of which is depicted in
FIG. 3 , the pressure release device is a piston-style dispenser 60, and pressure is maintained on thecomposition 5 by pressure of apiston 62. The pressure of thepiston 62 may be provided by placement of apressurized gas 64 beneath thepiston 62, which placement may be advantageously achieved by introducinggas 64 through agas charging port 66. Alternatively, pressure on the piston may be achieved by a spring loaded mechanism beneath the piston. Such piston-style dispensers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition contained therein. While it is not intended that the invention be limited by the design of the piston-style can, representative examples are set forth in U.S. Pat. No. 4,134,523 to Hansen. - In another excellent embodiment of the invention, representative examples of which are depicted in
FIGS. 4 and 5 , the pressure release device comprises a bag-in-can-style dispenser 70. The pressurized compartment of such a container is apolymeric bag 72 received inside arigid can 73. Pressure is maintained on thecomposition 5 inside thebag 72. In one aspect of the invention, a representative example of which is depicted inFIG. 4 , the pressure is maintained upon the composition by a pressurizinggas 74 received in thecan 73 and externally to thebag 72. The pressurizinggas 74 may be advantageously placed in thecan 73 by introducinggas 74 through agas charging port 76. In another aspect of the invention, an example of which is depicted inFIG. 5 , thebag 72 is an elastic shape-memory bag, and pressure is maintained upon thecomposition 5 by maintaining the bag in an expanded state. This type of container is commonly referred to as a bladder pack container. - A wide variety of bag-in-can-style containers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the composition contained therein. While it is not intended that the invention be limited by the design of the bag-in-can-style container, representative examples are set forth in U.S. Pat. No. 3,788,521 to Laauwe, U.S. Pat. No. 4,510,734 to Banks et al., and U.S. Pat. No. 5,249,747 to Hanson et al.
- Another atomizing spray dispenser that may be used in accordance with the invention, a representative example of which is shown in
FIG. 6 , is anaerosol device 80. As used herein, the term “aerosol device” is intended to refer to a device that delivers the diaper rash spray treatment composition by entraining the same in a carrier stream comprising an inertpressurized propellant gas 82. When such a device is actuated, the composition is released from the container, entrained in a gaseous stream, atomized, and propelled substantially in a predetermined direction by using energy provided by the pressurized gas. It is understood that the composition and carrier gas may alternately be contained in the container in a pre-mixed form, whereby actuation of the device results in a substantially constant release of the mixture. A wide variety of aerosol containers are commercially available, as are a wide variety of designs for actuating the dispensers and for atomizing the compositions contained therein. While it is not intended that the invention be limited by the design of the aerosol container, representative examples are set forth in U.S. Pat. No. 4,001,391 to Feinstone et al., U.S. Pat. No. 4,187,985 to Goth, U.S. Pat. No. 4,239,407 to Knight, U.S. Pat. No. 4,495,168 to Schmolka, U.S. Pat. No. 5,788,389 to de Laforcade, and U.S. Pat. No. RE030,093 to Burger. - While a wide variety of configurations and styles of atomizing spray dispensers are known in the art, the known prior art does not disclose or suggest the present invention, in which excellent diaper rash treatment compositions are delivered to a skin surface from an atomizing spray dispenser. In view of the above, an excellent system that may be used to achieve efficient treatment of diaper rash is depicted in
FIG. 1 and includes a diaper rash treatment composition as described herein and anatomizing spray dispenser 10 for atomizing the composition and delivering the atomized composition to a skin treatment area. Thedispenser 10 preferably comprises acontainer 20, an atomizingspray delivery mechanism 24 affixed to thecontainer 20, and thecomposition 5 positioned in thecontainer 20. The mechanism preferably comprises an inlet port in fluid communication with the interior of the container for receiving the composition, a device for atomizing the composition, and an outlet port for propelling the atomized composition substantially in a predetermined direction. It is readily understood that, in use, the inlet port must be in contact with the composition. - While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiments have been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
Claims (72)
1. A method for treating diaper rash, comprising:
providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container;
selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and
passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area;
wherein the composition comprises at least about 1 percent solid particulate material by weight and at least about 20 percent by weight of a fluid base material.
2. The method according to claim 1 , wherein the solid material comprises particulate zinc oxide.
3. The method according to claim 2 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 100 microns.
4. The method according to claim 2 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 10 microns.
5. The method according to claim 2 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 1 micron.
6. The method according to claim 2 , wherein the fluid base material is selected from the group consisting of mineral oil, silicone oil and a plant-based oil.
7. The method according to claim 6 , wherein the silicone oil is selected from the group consisting of cyclomethicone, dimethicone and derivatives thereof.
8. The method according to claim 2 , wherein the composition further comprises one or more member selected from the group consisting of talc, lanolin, cod liver oil, petrolatum, paraffin wax and microcrystalline wax.
9. The method according to claim 2 , wherein the composition comprises:
from about 1 percent to about 40 percent by weight zinc oxide;
from about 20 percent to about 99 percent by weight mineral oil;
from about 0 percent to about 20 percent by weight silicone oil;
from about 0 percent to about 12 percent by weight cod liver oil;
from about 0 percent to about 16 percent by weight lanolin;
from about 0 percent to about 25 percent by weight petrolatum; and
from about 0 percent to about 30 percent by weight water.
10. The method according to claim 2 , wherein the composition comprises:
from about 1 percent to about 40 percent by weight zinc oxide;
from about 0 percent to about 20 percent by weight mineral oil;
from about 20 percent to about 99 percent by weight silicone oil;
from about 0 percent to about 12 percent by weight cod liver oil;
from about 0 percent to about 16 percent by weight lanolin;
from about 0 percent to about 25 percent by weight petrolatum; and
from about 0 percent to about 30 percent by weight water.
11. The method according to claim 2 , wherein the composition comprises:
from about 5 percent to about 25 percent by weight zinc oxide; and
from about 33 percent to about 80 percent by weight fluid base material.
12. The method according to claim 1 , wherein the solid material is selected from the group consisting of talc, calamine and kaolin.
13. The method according to claim 1 , wherein the skin treatment area is the diaper area of a patient.
14. A method for treating diaper rash, comprising:
providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container;
selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and
passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area;
wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material.
15. The method according to claim 14 , wherein the fluid base material is selected from the group consisting of mineral oil and silicone oil.
16. The method according to claim 14 , wherein the fluid base material comprises cod liver oil.
17. The method according to claim 14 , wherein the composition comprises:
from about 1 percent to about 16 percent by weight lanolin;
from about 47 percent to about 97 percent by weight fluid base material;
from about 1 percent to about 12 percent by weight cod liver oil; and
from about 1 percent to about 25 percent by weight petrolatum.
18. The method according to claim 14 , wherein the composition comprises:
from about 5 percent to about 16 percent by weight lanolin;
from about 57 percent to about 85 percent by weight fluid base material;
from about 5 percent to about 12 percent by weight cod liver oil; and
from about 5 percent to about 15 percent by weight petrolatum.
19. The method according to claim 14 , wherein the skin treatment area is the diaper area of a patient.
20. A method for treating diaper rash, comprising:
providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the composition has a viscosity of from about 1 to about 1000 centipoise; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container;
selecting a skin treatment area featuring incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and
passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area;
wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey.
21. The method according to claim 20 , wherein the fluid base material is a plant-based oil.
22. The method according to claim 20 , wherein the fluid base material is selected from the group consisting of almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kernal oil, geranium oil, ricebran oil and mixtures thereof.
23. The method according to claim 20 , wherein the composition further comprises one or more member selected from the group consisting of cod liver oil, paraffin wax, microcrystalline wax and bees wax.
24. The method according to claim 20 , wherein the skin treatment area is the diaper area of a patient.
25. A system for treating diaper rash, the system comprising:
a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises at least about 1 percent particulate zinc oxide by weight and at least about 20 percent by weight of a fluid base material; and
an atomizing spray dispenser for delivering the composition to a skin treatment area;
wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and
wherein the composition is positioned in the container.
26. The system according to claim 25 , wherein the atomizing spray delivery mechanism comprises:
an inlet port in fluid communication with the interior of the container for receiving the composition;
a device for atomizing the composition; and
an outlet port exterior of the container for propelling the atomized composition substantially in a predetermined direction;
wherein the composition is in contact with the inlet port.
27. The system according to claim 25 , wherein the dispenser is an atomizing pump spray dispenser.
28. The system according to claim 25 , wherein the dispenser comprises a pressurized compartment, wherein the composition is releasably contained in the pressurized compartment and wherein the mechanism, when actuated, releases the composition as an atomized spray.
29. The system according to claim 28 , wherein the dispenser is a piston-style dispenser, and wherein pressure is maintained on the composition by pressure of the piston.
30. The system according to claim 28 , wherein the dispenser is a bag-in-can-style dispenser and wherein the pressurized compartment is a polymeric bag received inside a rigid can.
31. The system according to claim 30 , wherein pressure is maintained upon the composition by a pressurizing gas received in the can and externally to the bag.
32. The system according to claim 30 , wherein the bag is an elastic shape-memory bag, and wherein pressure is maintained upon the composition by maintaining the bag in an expanded state.
33. The system according to claim 25 , wherein the spray delivery mechanism comprises a manually actuated spray delivery mechanism.
34. The system according to claim 25 , wherein the spray delivery mechanism comprises a reciprocating actuator.
35. The system according to claim 25 , wherein the composition has a viscosity of from about 20 to about 650 centipoise.
36. The system according to claim 25 , wherein the composition has a viscosity of from about 100 to about 600 centipoise.
37. The system according to claim 25 , wherein the composition firther comprises a member selected from the group consisting of a fragrance, a dye, a preservative, an emollient, an anti-bacterial agent, an anti-fungal agent, talc, calamine, kaolin, lanolin, petrolatum, microcrystalline wax, paraffin wax, bees wax and a mixture thereof.
38. A method for treating diaper rash, comprising:
selecting a substantially clean skin treatment area afflicted by incontinent dermatitis or substantially at risk of developing incontinent dermatitis; and
propelling toward the skin treatment area an atomized spray comprising a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise. dispenser and sufficiently high that the coating does not run off of the skin treatment area; and
wherein the composition includes: (1) a fluid base material selected from the group consisting of mineral oil, silicone oil, plant-based oil, water and mixtures thereof, and (2) a member selected from the group consisting of a solid particulate material, lanolin, petrolatum, cod liver oil, calendula, chamomile, comfrey and mixtures thereof.
40. The method according to claim 39, wherein the composition comprises particulate zinc oxide.
41. The method according to claim 40 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 100 microns.
42. The method according to claim 40 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 10 microns.
43. The method according to claim 40 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 1 micron.
44. The method according to claim 40 , wherein the fluid base material is selected from the group consisting of mineral oil, silicone oil and a plant-based oil.
45. The method according to claim 44 , wherein the silicone oil is selected from the group consisting of cyclomethicone, dimethicone and derivatives thereof.
46. The method according to claim 40 , wherein the composition further comprises one or more member selected from the group consisting of talc, paraffin wax and microcrystalline wax.
47. The method according to claim 40 , wherein the composition comprises:
from about 5 percent to about 25 percent by weight zinc oxide; and
from about 33 percent to about 80 percent by weight fluid base material.
48. The method according to claim 39, wherein the solid material is selected from the group consisting of talc, calamine and kaolin.
49. The method according to claim 39 wherein the composition comprises lanolin, petrolatum, cod liver oil and a fluid base material.
50. The method according to claim 49 , wherein the fluid base material comprises cod liver oil.
51. The method according to claim 39 wherein the composition comprises a member selected from the group consisting of calendula, chamomile and comfrey, and wherein the fluid base material is a plant-based oil.
52. The method according to claim 51 , wherein the fluid base material is selected from the group consisting of almond oil, peanut oil, wheat germ oil, linseed oil, jojoba oil, apricot pit oil, walnut oil, palm nut oil, pistachio nut oil, sesame seed oil, rapeseed oil, cade oil, corn oil, peach pit oil, poppyseed oil, pine oil, castor oil, soybean oil, avocado oil, safflower oil, coconut oil, hazelnut oil, olive oil, grape seed oil, sunflower oil, apricot kernal oil, geranium oil, ricebran oil and mixtures thereof.
53. The method according to claim 51 , wherein the composition further comprises one or more member selected from the group consisting of cod liver oil, paraffin wax, microcrystalline wax and bees wax.
54. The method according to claim 39, wherein the composition has a viscosity of from about 1 to about 1000 centipoise.
55. The method according to claim 39, wherein the composition has a viscosity of from about 20 to about 650 centipoise.
56. The method according to claim 39, wherein the composition has a viscosity of from about 100 to about 600 centipoise.
57. The method according to claim 39, wherein the composition further comprises a member selected from the group consisting of a fragrance, a dye, a preservative, an emollient, an anti-bacterial agent, an anti-fungal agent, talc, calamine, kaolin, microcrystalline wax, paraffin wax, bees wax and a mixture thereof.
58. A method for treating diaper rash, comprising:
selecting a skin treatment area selected from the group consisting of (i) a skin area normally covered by a diaper, an incontinence pad or an incontinence brief and (ii) an area featuring incontinent dermatitis;
propelling toward the skin treatment area an atomized spray comprising a fluid diaper rash treatment composition; and
leaving the composition on the skin treatment area to form a coating wherein the composition has a viscosity sufficiently low to allow the composition to be atomized upon passage through the atomizing spray dispenser and sufficiently high that the coating does not run off of the skin treatment area; and
wherein the composition comprises a fluid base material selected from the group consisting of mineral oil, silicone oil, plant-based oil, water and mixtures thereof, and a member selected from the group consisting of a solid particulate material, lanolin, petrolatum, cod liver oil, calendula, chamomile, comfrey and mixtures thereof.
59. A method for treating diaper rash, comprising:
providing a diaper rash treatment system comprising an atomizing spray dispenser and a diaper rash treatment composition; wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and wherein the composition is positioned in the container;
selecting a skin treatment area selected from the group consisting of (i) a skin area normally covered by a diaper, an incontinence pad or an incontinence brief and (ii) an area featuring incontinent dermatitis;
passing the composition through the mechanism to atomize the composition and to propel the atomized composition toward the skin treatment area; and
leaving the composition on the skin treatment area to form a coating;
wherein the composition is a fluid composition having a viscosity sufficiently low to allow the composition to be atomized upon passage through the atomizing spray dispenser and sufficiently high that the coating does not run off of the skin treatment area; and
wherein the composition includes: (1) a fluid base material selected from the group consisting of mineral oil, silicone oil, plant-based oil, water and mixtures thereof, and (2) a particulate zinc oxide material, the zinc oxide material having a particle size whereby at least a portion of the zinc oxide is transparent in the composition.
60. The method according to claim 59 , wherein the particulate zinc oxide has an average particle size of from about 0.01 microns to about 0.1 micron.
61. A system for treating diaper rash, the system comprising:
a diaper rash treatment composition having a viscosity of from about 1 to about 1000 centipoise, wherein the composition comprises at least about 1 percent particulate zinc oxide by weight and at least about 20 percent by weight of a fluid base material; and
an atomizing spray dispenser for delivering the composition to a skin treatment area;
wherein the dispenser comprises a container and an atomizing spray delivery mechanism affixed to the container; and
wherein the composition is positioned in the container.
62. The system according to claim 61 , wherein the atomizing spray delivery mechanism comprises:
an inlet port in fluid communication with the interior of the container for receiving the composition;
a device for atomizing the composition; and
an outlet port exterior of the container for propelling the atomized composition substantially in a predetermined direction;
wherein the composition is in contact with the inlet port.
63. The system according to claim 61 , wherein the dispenser is an atomizing pump spray dispenser.
64. The system according to claim 61 , wherein the dispenser comprises a pressurized compartment, wherein the composition is releasably contained in the pressurized compartment and wherein the mechanism, when actuated, releases the composition as an atomized spray.
65. The system according to claim 64 , wherein the dispenser is a piston-style dispenser, and wherein pressure is maintained on the composition by pressure of the piston.
66. The system according to claim 64 , wherein the dispenser is a bag-in-can-style dispenser and wherein the pressurized compartment is a polymeric bag received inside a rigid can.
67. The system according to claim 66 , wherein pressure is maintained upon the composition by a pressurizing gas received in the can and externally to the bag.
68. The system according to claim 66 , wherein the bag is an elastic shape-memory bag, and wherein pressure is maintained upon the composition by maintaining the bag in an expanded state.
69. The system according to claim 61 , wherein the spray delivery mechanism comprises a manually actuated spray delivery mechanism.
70. The system according to claim 61 , wherein the spray delivery mechanism comprises a reciprocating actuator.
71. The system according to claim 61 , wherein the composition has a viscosity of from about 20 to about 650 centipoise.
72. The system according to claim 61 , wherein the composition has a viscosity of from about 100 to about 600 centipoise.
73. The system according to claim 61 , wherein the composition further comprises a member selected from the group consisting of a fragrance, a dye, a preservative, an emollient, an anti-bacterial agent, an anti-fungal agent, talc, calamine, kaolin, lanolin, petrolatum, microcrystalline wax, paraffin wax, bees wax and a mixture thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/626,069 US20050079229A1 (en) | 1999-07-30 | 2003-07-24 | Methods, compositions and systems for the prevention and treatment of diaper rash |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/364,133 US6627178B1 (en) | 1999-07-30 | 1999-07-30 | Methods, compositions and systems for the prevention and treatment of diaper rash |
| US10/626,069 US20050079229A1 (en) | 1999-07-30 | 2003-07-24 | Methods, compositions and systems for the prevention and treatment of diaper rash |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/364,133 Continuation US6627178B1 (en) | 1999-07-30 | 1999-07-30 | Methods, compositions and systems for the prevention and treatment of diaper rash |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20050079229A1 true US20050079229A1 (en) | 2005-04-14 |
Family
ID=28454600
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/364,133 Expired - Lifetime US6627178B1 (en) | 1999-07-30 | 1999-07-30 | Methods, compositions and systems for the prevention and treatment of diaper rash |
| US10/626,069 Abandoned US20050079229A1 (en) | 1999-07-30 | 2003-07-24 | Methods, compositions and systems for the prevention and treatment of diaper rash |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/364,133 Expired - Lifetime US6627178B1 (en) | 1999-07-30 | 1999-07-30 | Methods, compositions and systems for the prevention and treatment of diaper rash |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US6627178B1 (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060292109A1 (en) * | 2005-06-22 | 2006-12-28 | Bristol-Myers Squibb Company | Enzyme inhibiting sprayable compositions |
| US20070218143A1 (en) * | 2006-03-20 | 2007-09-20 | Chong Mok T M | Topical preparation |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
| US10064795B2 (en) | 2015-05-22 | 2018-09-04 | Grip Tight Sport Llc | Atomizing spray for grip enhancement |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6949249B2 (en) | 2000-05-08 | 2005-09-27 | Pfizer Inc. | Skin protectant spray compositions |
| US20040156793A1 (en) * | 2003-02-11 | 2004-08-12 | Golden Chiropractic Group Ltd. | Skin care composition and method of skin treatment |
| US8211449B2 (en) * | 2004-06-24 | 2012-07-03 | Dpt Laboratories, Ltd. | Pharmaceutically elegant, topical anhydrous aerosol foam |
| US20060171914A1 (en) * | 2005-01-31 | 2006-08-03 | Danles Amy M | Botanically derived cleanser |
| KR101326679B1 (en) | 2007-11-30 | 2013-11-08 | (주)아모레퍼시픽 | Skin external composition for treating or alleviating diaper rash containing zinc oxide stabilized by polyglyceryl-2 dipolyhydroxystearate |
| US8088829B2 (en) * | 2009-09-09 | 2012-01-03 | Howard Martin | Biocidal aldehyde composition |
| WO2013023035A1 (en) | 2011-08-09 | 2013-02-14 | Herron Brandy K | Prevention and treatment of groin dermatitis methods and systems |
| US8932656B1 (en) | 2011-09-20 | 2015-01-13 | Aja Henderson | Oil blend for skin treatment |
| US9446089B1 (en) | 2011-09-20 | 2016-09-20 | Aja Henderson | Oil blend for skin treatment |
| US9717679B1 (en) * | 2012-12-17 | 2017-08-01 | Touchless Designs LLC | Methods for the prevention and treatment of animal skin conditions |
| US20160331863A1 (en) * | 2013-12-18 | 2016-11-17 | Crawford Wondcare Ltd. | Methods for the prevention and treatment of skin problems exacerbated by moisture and/or friction |
| AU2015217275B2 (en) | 2014-02-14 | 2019-11-21 | Mission Pharmacal Company | Stabilized, sprayable emulsion containing active agent particles |
| ES2894679T3 (en) | 2014-02-14 | 2022-02-15 | Mission Pharma Co | Sprayable composition containing zinc oxide and a fluoro-olefin propellant |
| CA2936409C (en) | 2014-02-14 | 2023-03-14 | Mission Pharmacal Company | Spray delivery device |
| US11931379B2 (en) | 2015-12-22 | 2024-03-19 | Johnson & Johnson Consumer Inc. | Stable foaming composition and method of use |
| TR202021776A2 (en) * | 2020-12-25 | 2022-07-21 | Eczacibasi Tueketim Ueruenleri Sanayi Ve Ticaret Anonim Sirketi | A COMPOSITION CONTAINING NATURAL HERBAL OILS AND A SKIN CARE PRODUCT CONTAINING THIS COMPOSITION |
Citations (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3079299A (en) * | 1959-11-16 | 1963-02-26 | Gen Aerosol Corp | Self-propelling medicinal ointment composition containing polyethylene and method ofapplication |
| US3584115A (en) * | 1968-05-31 | 1971-06-08 | Arthur Ira Gebhart | Method of applying visible aerosol compositions |
| US3788521A (en) * | 1972-07-10 | 1974-01-29 | Laauwe Robert H | Aerosol package |
| US4001391A (en) * | 1969-04-18 | 1977-01-04 | Plough, Inc. | Means for depositing aerosol sprays in buttery form |
| US4082222A (en) * | 1975-08-14 | 1978-04-04 | Michel Boris | Atomized liquid dispensing pump |
| US4134523A (en) * | 1977-05-09 | 1979-01-16 | Southern Can Company | Vented piston for barrier pressure containers |
| USRE30093E (en) * | 1975-01-27 | 1979-09-11 | Aerosol dispensing system | |
| US4187985A (en) * | 1978-12-08 | 1980-02-12 | The Continental Group, Inc. | Aerosol valve for barrier type packages |
| US4239407A (en) * | 1979-02-22 | 1980-12-16 | Knight Hester L | Hard to reach places spray can |
| US4307089A (en) * | 1979-08-02 | 1981-12-22 | Rewo Chemische Werke Gmbh | Compositions of pyrithione metal salts and undecylenic acid alkylolamide derivatives |
| US4382919A (en) * | 1980-09-15 | 1983-05-10 | Bristol-Myers Company | Composition for treatment and prevention of malodorous generating skin conditions |
| US4389418A (en) * | 1981-02-25 | 1983-06-21 | S. C. Johnson & Son, Inc. | Skin care composition |
| US4495168A (en) * | 1983-08-22 | 1985-01-22 | Basf Wyandotte Corporation | Aerosol gel |
| US4510734A (en) * | 1980-07-25 | 1985-04-16 | Enviro-Spray Systems Incorporated | Expandable bag and method of manufacture |
| US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
| US4816254A (en) * | 1987-07-29 | 1989-03-28 | Moss Thomas D | Ointment for treating skin irritations |
| US4857321A (en) * | 1988-08-26 | 1989-08-15 | Thomas William C | Skin ointment |
| US4893956A (en) * | 1988-11-18 | 1990-01-16 | Blistex Inc. | Packaging for medicaments |
| US4937234A (en) * | 1988-08-10 | 1990-06-26 | Fahim Mostafa S | Minerals in bioavailable form |
| US4963591A (en) * | 1985-12-16 | 1990-10-16 | Carter-Wallace Inc. | Cosmetic compositions |
| US4981677A (en) * | 1987-09-23 | 1991-01-01 | L'oreal | Petrolatum-containing aerosol foam concentrate |
| US4996238A (en) * | 1988-09-16 | 1991-02-26 | Neutrogena Corporation | Method of treating diaper rash |
| US4996239A (en) * | 1988-09-16 | 1991-02-26 | Neutrogena Corporation | Water resistant cream conditioner |
| US5091193A (en) * | 1989-08-23 | 1992-02-25 | Roussel Uclaf | Diaper rash treatment and compositions |
| US5110593A (en) * | 1990-11-13 | 1992-05-05 | Benford M Sue | Irradication and treatment of diaper dermatitis and related skin disorders |
| US5126136A (en) * | 1988-08-05 | 1992-06-30 | Merat Pierre H | Skin protection lotion |
| US5169037A (en) * | 1990-01-26 | 1992-12-08 | Ccl Industries Inc. | Product bag for dispensing and method for producing the same |
| US5176903A (en) * | 1990-12-13 | 1993-01-05 | Revlon Consumer Products Corporation | Antiperspirant/deodorant containing microcapsules |
| US5194261A (en) * | 1990-11-27 | 1993-03-16 | Virgil Pichierri | Diaper rash treatment |
| US5223250A (en) * | 1991-02-05 | 1993-06-29 | Sun Smart, Inc. | Visibly transparent UV sunblock cosmetic compositions |
| US5229105A (en) * | 1986-05-28 | 1993-07-20 | Donald Basiliere | Multi-active skin preparation |
| US5249747A (en) * | 1990-07-12 | 1993-10-05 | Par-Way Group | Sprayable dispensing system for viscous vegetable oils and apparatus therefor |
| US5256403A (en) * | 1987-01-05 | 1993-10-26 | Gaskin Frances C | Composition and method for protecting the skin from UV-rays |
| US5300286A (en) * | 1992-07-14 | 1994-04-05 | Dow Corning Corporation | Silicone emulsion for personal care application |
| US5330756A (en) * | 1990-10-18 | 1994-07-19 | Steuart Gary M | Polyphase fluid extraction process, resulting products and methods of use |
| US5362488A (en) * | 1992-10-23 | 1994-11-08 | Abbott Laboratories | Buffered diaper rash cream |
| US5366660A (en) * | 1991-10-04 | 1994-11-22 | Tioxide Specialties Limited | Dispersions |
| US5409903A (en) * | 1992-02-18 | 1995-04-25 | Urecap Corporation | Method and compositions for the treatment of H. pylori and dermatitis |
| US5417961A (en) * | 1993-04-30 | 1995-05-23 | Colgate-Palmolive Company | Sunscreen compositions |
| US5436007A (en) * | 1992-10-23 | 1995-07-25 | Abbott Laboratories | Diaper rash lotion |
| US5441726A (en) * | 1993-04-28 | 1995-08-15 | Sunsmart, Inc. | Topical ultra-violet radiation protectants |
| US5455033A (en) * | 1993-05-21 | 1995-10-03 | Degree/Silverman M.D. Inc. | Medicinal composition for treatment of inflammation |
| US5486631A (en) * | 1995-06-14 | 1996-01-23 | Siltech Inc. | Silicone polymers for the modification of zinc oxide |
| US5527519A (en) * | 1992-12-18 | 1996-06-18 | Bayer Aktiengesellschaft | Finely divided, highly pure neutral zinc oxide powder, a process for its preparation and its use |
| US5536492A (en) * | 1995-06-14 | 1996-07-16 | Siltech Inc. | Cosmetic compositions containing hydrophobized zinc oxide |
| US5536502A (en) * | 1995-02-03 | 1996-07-16 | Gerit D. Mulder | Skin-tear medicament and method of use |
| US5582818A (en) * | 1994-01-27 | 1996-12-10 | Ajinomoto Co., Inc. | Ultraviolet screening powder and cosmetics |
| US5587148A (en) * | 1991-02-05 | 1996-12-24 | Sunsmart, Inc. | Visibly transparent UV sunblock agents and methods of making same |
| US5609854A (en) * | 1995-06-06 | 1997-03-11 | Elizabeth Arden Company, Division Of Conopco, Inc. | Thickened and stabilized cosmetic emulsion compositions |
| US5609852A (en) * | 1992-05-16 | 1997-03-11 | The Boots Company Plc | Sunscreen with coated microfine particles |
| US5639025A (en) * | 1995-07-07 | 1997-06-17 | The Procter & Gamble Company | High Viscosity pump sprayer utilizing fan spray nozzle |
| US5652274A (en) * | 1991-03-01 | 1997-07-29 | Martin; Alain | Therapeutic-wound healing compositions and methods for preparing and using same |
| US5658956A (en) * | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
| US5674912A (en) * | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
| US5721306A (en) * | 1995-06-07 | 1998-02-24 | Amcol International Corporation | Viscous carrier compositions, including gels, formed with an organic liquid carrier and a layered material:polymer complex |
| US5744469A (en) * | 1996-11-26 | 1998-04-28 | Eli Lilly And Company | Method for treating dermatitis |
| US5762945A (en) * | 1996-04-05 | 1998-06-09 | Ashley; Eline | Composition and method for treating diaper rash |
| US5788389A (en) * | 1995-08-02 | 1998-08-04 | L'oreal | Dispenser and package for a pressurized liquid |
| US5869071A (en) * | 1996-11-07 | 1999-02-09 | B & G Labs, Inc. | One-step skin cleaning composition and skin treatment method for incontinent dermatitis |
| US5874479A (en) * | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US5876688A (en) * | 1993-08-06 | 1999-03-02 | Elementis Uk Limited | Zinc oxide and a process of making it |
| US5881925A (en) * | 1996-03-22 | 1999-03-16 | Mitani Valve Co. | Atomizer of reciprocating pump type |
| US5961957A (en) * | 1997-10-20 | 1999-10-05 | Mcanalley; Bill H. | Foam compositions |
| US6103247A (en) * | 1994-03-11 | 2000-08-15 | L'oreal | Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| US6103245A (en) * | 1996-05-21 | 2000-08-15 | Derma Sciences, Inc. | Topical barrier composition containing silicone and bentonite |
| US6217890B1 (en) * | 1998-08-25 | 2001-04-17 | Susan Carol Paul | Absorbent article which maintains or improves skin health |
| US6423323B2 (en) * | 1997-08-18 | 2002-07-23 | Stephanie Neubourg | Foam skin cream, uses of the foam skin protection cream and a process for its preparation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4010574B2 (en) | 1994-12-05 | 2007-11-21 | 電気化学工業株式会社 | Topical skin preparation |
-
1999
- 1999-07-30 US US09/364,133 patent/US6627178B1/en not_active Expired - Lifetime
-
2003
- 2003-07-24 US US10/626,069 patent/US20050079229A1/en not_active Abandoned
Patent Citations (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3079299A (en) * | 1959-11-16 | 1963-02-26 | Gen Aerosol Corp | Self-propelling medicinal ointment composition containing polyethylene and method ofapplication |
| US3584115A (en) * | 1968-05-31 | 1971-06-08 | Arthur Ira Gebhart | Method of applying visible aerosol compositions |
| US4001391A (en) * | 1969-04-18 | 1977-01-04 | Plough, Inc. | Means for depositing aerosol sprays in buttery form |
| US3788521A (en) * | 1972-07-10 | 1974-01-29 | Laauwe Robert H | Aerosol package |
| USRE30093E (en) * | 1975-01-27 | 1979-09-11 | Aerosol dispensing system | |
| US4082222A (en) * | 1975-08-14 | 1978-04-04 | Michel Boris | Atomized liquid dispensing pump |
| US4134523A (en) * | 1977-05-09 | 1979-01-16 | Southern Can Company | Vented piston for barrier pressure containers |
| US4187985A (en) * | 1978-12-08 | 1980-02-12 | The Continental Group, Inc. | Aerosol valve for barrier type packages |
| US4239407A (en) * | 1979-02-22 | 1980-12-16 | Knight Hester L | Hard to reach places spray can |
| US4307089A (en) * | 1979-08-02 | 1981-12-22 | Rewo Chemische Werke Gmbh | Compositions of pyrithione metal salts and undecylenic acid alkylolamide derivatives |
| US4510734A (en) * | 1980-07-25 | 1985-04-16 | Enviro-Spray Systems Incorporated | Expandable bag and method of manufacture |
| US4382919A (en) * | 1980-09-15 | 1983-05-10 | Bristol-Myers Company | Composition for treatment and prevention of malodorous generating skin conditions |
| US4389418A (en) * | 1981-02-25 | 1983-06-21 | S. C. Johnson & Son, Inc. | Skin care composition |
| US4556560A (en) * | 1983-01-24 | 1985-12-03 | The Procter & Gamble Company | Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis |
| US4495168A (en) * | 1983-08-22 | 1985-01-22 | Basf Wyandotte Corporation | Aerosol gel |
| US4963591A (en) * | 1985-12-16 | 1990-10-16 | Carter-Wallace Inc. | Cosmetic compositions |
| US5229105A (en) * | 1986-05-28 | 1993-07-20 | Donald Basiliere | Multi-active skin preparation |
| US5256403A (en) * | 1987-01-05 | 1993-10-26 | Gaskin Frances C | Composition and method for protecting the skin from UV-rays |
| US4816254A (en) * | 1987-07-29 | 1989-03-28 | Moss Thomas D | Ointment for treating skin irritations |
| US4981677A (en) * | 1987-09-23 | 1991-01-01 | L'oreal | Petrolatum-containing aerosol foam concentrate |
| US5126136A (en) * | 1988-08-05 | 1992-06-30 | Merat Pierre H | Skin protection lotion |
| US4937234A (en) * | 1988-08-10 | 1990-06-26 | Fahim Mostafa S | Minerals in bioavailable form |
| US4857321A (en) * | 1988-08-26 | 1989-08-15 | Thomas William C | Skin ointment |
| US4996239A (en) * | 1988-09-16 | 1991-02-26 | Neutrogena Corporation | Water resistant cream conditioner |
| US4996238A (en) * | 1988-09-16 | 1991-02-26 | Neutrogena Corporation | Method of treating diaper rash |
| US4893956A (en) * | 1988-11-18 | 1990-01-16 | Blistex Inc. | Packaging for medicaments |
| US5091193A (en) * | 1989-08-23 | 1992-02-25 | Roussel Uclaf | Diaper rash treatment and compositions |
| US5169037A (en) * | 1990-01-26 | 1992-12-08 | Ccl Industries Inc. | Product bag for dispensing and method for producing the same |
| US5249747A (en) * | 1990-07-12 | 1993-10-05 | Par-Way Group | Sprayable dispensing system for viscous vegetable oils and apparatus therefor |
| US5330756A (en) * | 1990-10-18 | 1994-07-19 | Steuart Gary M | Polyphase fluid extraction process, resulting products and methods of use |
| US5110593A (en) * | 1990-11-13 | 1992-05-05 | Benford M Sue | Irradication and treatment of diaper dermatitis and related skin disorders |
| US5194261A (en) * | 1990-11-27 | 1993-03-16 | Virgil Pichierri | Diaper rash treatment |
| US5618529A (en) * | 1990-11-27 | 1997-04-08 | Pichierri; Virgil F. | Diaper rash treatment |
| US5176903A (en) * | 1990-12-13 | 1993-01-05 | Revlon Consumer Products Corporation | Antiperspirant/deodorant containing microcapsules |
| US5223250A (en) * | 1991-02-05 | 1993-06-29 | Sun Smart, Inc. | Visibly transparent UV sunblock cosmetic compositions |
| US5587148C1 (en) * | 1991-02-05 | 2001-11-20 | Basf Corp | Visibly transparent uv sunblock agents and methods of making same |
| US5531985A (en) * | 1991-02-05 | 1996-07-02 | Sunsmart, Inc. | Visibly transparent UV sunblock compositions and cosmetic products containing the same |
| US5587148A (en) * | 1991-02-05 | 1996-12-24 | Sunsmart, Inc. | Visibly transparent UV sunblock agents and methods of making same |
| US5874479A (en) * | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
| US5674912A (en) * | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
| US5658956A (en) * | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
| US5652274A (en) * | 1991-03-01 | 1997-07-29 | Martin; Alain | Therapeutic-wound healing compositions and methods for preparing and using same |
| US5366660A (en) * | 1991-10-04 | 1994-11-22 | Tioxide Specialties Limited | Dispersions |
| US5409903A (en) * | 1992-02-18 | 1995-04-25 | Urecap Corporation | Method and compositions for the treatment of H. pylori and dermatitis |
| US5609852A (en) * | 1992-05-16 | 1997-03-11 | The Boots Company Plc | Sunscreen with coated microfine particles |
| US5300286A (en) * | 1992-07-14 | 1994-04-05 | Dow Corning Corporation | Silicone emulsion for personal care application |
| US5436007A (en) * | 1992-10-23 | 1995-07-25 | Abbott Laboratories | Diaper rash lotion |
| US5362488A (en) * | 1992-10-23 | 1994-11-08 | Abbott Laboratories | Buffered diaper rash cream |
| US5527519A (en) * | 1992-12-18 | 1996-06-18 | Bayer Aktiengesellschaft | Finely divided, highly pure neutral zinc oxide powder, a process for its preparation and its use |
| US5441726A (en) * | 1993-04-28 | 1995-08-15 | Sunsmart, Inc. | Topical ultra-violet radiation protectants |
| US5417961A (en) * | 1993-04-30 | 1995-05-23 | Colgate-Palmolive Company | Sunscreen compositions |
| US5455033A (en) * | 1993-05-21 | 1995-10-03 | Degree/Silverman M.D. Inc. | Medicinal composition for treatment of inflammation |
| US5876688A (en) * | 1993-08-06 | 1999-03-02 | Elementis Uk Limited | Zinc oxide and a process of making it |
| US5582818A (en) * | 1994-01-27 | 1996-12-10 | Ajinomoto Co., Inc. | Ultraviolet screening powder and cosmetics |
| US6103247A (en) * | 1994-03-11 | 2000-08-15 | L'oreal | Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| US5536502A (en) * | 1995-02-03 | 1996-07-16 | Gerit D. Mulder | Skin-tear medicament and method of use |
| US5609854A (en) * | 1995-06-06 | 1997-03-11 | Elizabeth Arden Company, Division Of Conopco, Inc. | Thickened and stabilized cosmetic emulsion compositions |
| US5721306A (en) * | 1995-06-07 | 1998-02-24 | Amcol International Corporation | Viscous carrier compositions, including gels, formed with an organic liquid carrier and a layered material:polymer complex |
| US5486631A (en) * | 1995-06-14 | 1996-01-23 | Siltech Inc. | Silicone polymers for the modification of zinc oxide |
| US5536492A (en) * | 1995-06-14 | 1996-07-16 | Siltech Inc. | Cosmetic compositions containing hydrophobized zinc oxide |
| US5639025A (en) * | 1995-07-07 | 1997-06-17 | The Procter & Gamble Company | High Viscosity pump sprayer utilizing fan spray nozzle |
| US5788389A (en) * | 1995-08-02 | 1998-08-04 | L'oreal | Dispenser and package for a pressurized liquid |
| US5881925A (en) * | 1996-03-22 | 1999-03-16 | Mitani Valve Co. | Atomizer of reciprocating pump type |
| US5762945A (en) * | 1996-04-05 | 1998-06-09 | Ashley; Eline | Composition and method for treating diaper rash |
| US6103245A (en) * | 1996-05-21 | 2000-08-15 | Derma Sciences, Inc. | Topical barrier composition containing silicone and bentonite |
| US5869071A (en) * | 1996-11-07 | 1999-02-09 | B & G Labs, Inc. | One-step skin cleaning composition and skin treatment method for incontinent dermatitis |
| US5744469A (en) * | 1996-11-26 | 1998-04-28 | Eli Lilly And Company | Method for treating dermatitis |
| US6423323B2 (en) * | 1997-08-18 | 2002-07-23 | Stephanie Neubourg | Foam skin cream, uses of the foam skin protection cream and a process for its preparation |
| US5961957A (en) * | 1997-10-20 | 1999-10-05 | Mcanalley; Bill H. | Foam compositions |
| US6217890B1 (en) * | 1998-08-25 | 2001-04-17 | Susan Carol Paul | Absorbent article which maintains or improves skin health |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060292109A1 (en) * | 2005-06-22 | 2006-12-28 | Bristol-Myers Squibb Company | Enzyme inhibiting sprayable compositions |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7927614B2 (en) | 2006-02-03 | 2011-04-19 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US8148563B2 (en) | 2006-02-03 | 2012-04-03 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US20070218143A1 (en) * | 2006-03-20 | 2007-09-20 | Chong Mok T M | Topical preparation |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US8505730B2 (en) | 2008-01-04 | 2013-08-13 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US9427397B2 (en) | 2009-01-23 | 2016-08-30 | Obagi Medical Products, Inc. | Rosacea treatments and kits for performing them |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US10064795B2 (en) | 2015-05-22 | 2018-09-04 | Grip Tight Sport Llc | Atomizing spray for grip enhancement |
Also Published As
| Publication number | Publication date |
|---|---|
| US6627178B1 (en) | 2003-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6627178B1 (en) | Methods, compositions and systems for the prevention and treatment of diaper rash | |
| KR101006258B1 (en) | Sanitary napkins containing hydrophobic lotions | |
| US5538732A (en) | Medicated applicator sheet for topical drug delivery | |
| JP3911161B2 (en) | Spray composition for skin protection | |
| CN101400329B (en) | Absorbent articles with lotions | |
| US6001380A (en) | Medicated applicator sheet for topical drug delivery | |
| US6589537B2 (en) | Infant skin care composition | |
| US20140257216A1 (en) | Sanitary napkins with hydrophobic lotions | |
| GB2335596A (en) | Polyalkyleneglycol Copolymers as Lipase Inhibitors | |
| MXPA06002166A (en) | Skin care topical ointment. | |
| JP2007524639A (en) | Method for producing a wet wipe using a concentrated emulsion | |
| US20110086085A1 (en) | Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same | |
| JP2007501249A (en) | Emulsion composition | |
| WO2011045682A2 (en) | Active agent containing polymer network delivery composition and articles using the same | |
| KR20020025750A (en) | Absorbent articles and barrier agent for the absorbent articles | |
| US20150044309A1 (en) | Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash | |
| KR100233770B1 (en) | Pharmaceutical Compositions for Skin Pain and Dosing | |
| US20160331863A1 (en) | Methods for the prevention and treatment of skin problems exacerbated by moisture and/or friction | |
| WO2004105689A2 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
| US20160045412A1 (en) | Antifungal, antibacterial topical composition for the prevention and treatment of various skin conditions including diaper rash | |
| KR20010089699A (en) | Spray-Type Cosmetic Composition And Matrix Used in Said Composition For Dermal Administration | |
| CN102100438A (en) | Product dispenser | |
| US9717679B1 (en) | Methods for the prevention and treatment of animal skin conditions | |
| EP0609330A1 (en) | Composition for topical application | |
| EP3184098B1 (en) | Foaming composition for diaper rash |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
| AS | Assignment |
Owner name: SYSTAGENIX WOUND MANAGEMENT, LIMITED, UNITED KINGD Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CRAWFORD WOUNDCARE LIMITED;REEL/FRAME:048038/0570 Effective date: 20181231 |